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Preface 
 
Exercise immunology is a relatively recent new area of research world 
wide, with an exponential growth in published papers after 1975. In Portugal, 
this research area was almost ignored and, until recently, been confined to the 
Medical Departments of Immunology. Only now have the Sport and Exercise 
Scientist in Portugal started to take notice of the research questions associated 
with exercise immunology. Reports from athletes, coaches and team doctors 
that athletes seemed to have a high incidence of infections (mainly from the 
upper respiratory tract) have sparkled the interest in this area. Since then some 
epidemiological studies appear to have confirmed that during heavy training and 
following competitive prolonged exercise events, endurance athletes seem to be 
more susceptible to infections of the upper respiratory tract (URTI). Several 
studies indicate that prolonged exercise may result in a temporary depression of 
the immune system and that chronic impairment of immune function can occur 
during periods of intensified training. On the other hand, moderate regular 
exercise seems to be associated with an improved immune function and a 
reduced incidence of URTI when compared to sedentary lifestyle.  
The researchers are now looking at the possible mechanisms by which 
exercise improves or impairs immune function. In this book authors report on 
intervention studies aimed at investigating the effects of diet and nutritional 
supplements on immune responses to exercise, looked at environmental factors 
like altitude, and provided helpful information that can be used by the coaches 
and team doctors in the management of athletes. 
This book is a compilation of the first conferences organized in 
Portugal by a sport sciences research group (Centro de Estudos Biocinéticos) 
from the Faculty of Sports Science and Physical Education, University of 
Coimbra, and represents a first step for the development and introduction of 
this area of research as an area of study in sport and exercise science degree 
programs in Portugal.  
I would like to thank all the authors of this book for their valuable 
contributions and wiliness to make time in their recognized carriers to visit 
Coimbra, do the conferences and write the articles that we can now all enjoy. 
 
 8 
The relevance of salivary IgA for the immunological 
management of athletes  
Robin Callister+ and Maree Gleeson* 
+School of Biomedical Sciences, Faculty of Health, The University of 
Newcastle Callaghan, NSW 2308, AUSTRALIA 
*Office of Science and Medical Research, GPO Box 5341, Sydney NSW 2001, 
AUSTRALIA 
 
 
Abstract 
This review examines the relevance of salivary IgA (Sal-IgA) to immunological 
health and successful sports performance in athletes. The consequences of 
alterations in Sal-IgA for infection risk, and the effects of acute exercise and 
exercise training on Sal-IgA secretion in this context are examined, as well as 
issues relating to the practicality of Sal-IgA measurement and monitoring. 
Routine Sal-IgA monitoring in asymptomatic athletes may be neither feasible 
nor justified, but monitoring athletes with ongoing or recurrent symptoms of 
illness may be beneficial. The current status of a number of strategies that may 
be useful in increasing Sal-IgA levels are provided.  
 
Keywords 
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Introduction 
 
Successful athletic performance requires appropriate training and optimal 
performance in competition. Illness that restricts training or compromises 
competitive sports performance has long been of concern to athletes, coaches 
and sports medicine professionals. Athletes vary in their susceptibility to illness, 
and one aspect of this variation is the competence and resilience of the immune 
system. One of the most common types of infectious illness experienced by 
athletes is upper respiratory tract infection (URTI) [7]. Strategies to prevent or 
limit URTI in athletes have led investigators to explore the impact of exercise 
on changes in mucosal immune function, measured by salivary immunoglobulin 
A (Sal-IgA).  
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This review will examine the role of Sal-IgA in the health and performance of 
athletes. The consequences of variations in Sal-IgA are presented, followed by a 
summary of the effects of exercise on Sal-IgA levels; the practicalities of routine 
measurement of Sal-IgA in athletes; the role of Sal-IgA monitoring; and the 
potential for interventions to enhance Sal-IgA status. 
 
What is secretory IgA (SIgA) and what does it do? 
 
IgA is the major antibody class in the Common Mucosal Immune System 
(CMIS), which is a component of the acquired (specific) immune system and 
the CMIS is the largest immune organ in the body. The CMIS consists of a 
network of immune structures at mucosal surfaces throughout the body 
including the respiratory, gastrointestinal and uro-genital tracts, salivary, lacrimal 
and lactating mammary glands, as well as bronchus-associated, gut-associated 
and nasal-associated lymphoid tissues. The SIgA antibodies are secreted onto 
mucosal surfaces in a dimeric form as Secretory IgA (SIgA) and provide specific 
local immunity for protection against pathogens including bacteria, viruses, 
allergens and antigens presented at mucosal surfaces.  
 
What happens if levels of SIgA at mucosal surfaces are low? 
 
SIgA is important in both exercising and non-exercising populations. 
Measuring changes in mucosal immunity has been monitored most often by 
measuring IgA concentrations in saliva (Sal-IgA). Studies indicate that there is a 
critical level of SIgA required at mucosal surfaces to prevent infections and 
subsequent detrimental health outcomes. Individuals with reduced SIgA levels 
are at greater risk of developing infections, especially URTI and gastrointestinal 
tract (GIT) infections.  
 
Some people have a SIgA deficiency. Fortunately, the immune system has 
some built in redundancy, and those with a SIgA deficiency are more dependent 
on the secretory immunoglobulin M (SIgM) class of antibodies; however, 
individuals with an IgA deficiency still experience a higher incidence of 
infections, especially URTI and GIT infections.  
 
What infections are common in athletes? 
 
The two most common groups of infections in athletes are URTI and GIT 
infections [7]. These infections can have substantial negative effects on an 
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athlete’s capacity to train and/or compete with optimal performance. Therefore 
it is desirable for athletes to reduce their risk of such infections. One strategy is 
to reduce the risk of exposure to pathogens, but it is also desirable to maintain 
mucosal immune protection through appropriate levels of SIgA. Athletes are 
not only at risk of exposure to new pathogens, as reactivation of viruses such as 
Epstein-Barr virus (EBV) to which an athlete has previously been exposed may 
also be a consequence of reduced levels of SIgA [14]. 
 
Why is SIgA measured in saliva? 
 
Measurement of the concentration of SIgA in saliva (Sal-IgA) is a common 
means of assessing mucosal immune status due to the ease of collecting saliva 
samples. Unfortunately there is considerable variability in Sal-IgA 
concentrations [6], due to both analytical and biological factors, which have 
been reviewed previously [16]. This means that great care must be taken in the 
interpretation of changes in Sal-IgA measurements.  
 
Does exercise influence the levels of Sal-IgA in athletes? 
 
The impact of exercise on Sal-IgA depends on the characteristics of the 
exercise and the training status of the athlete [15]. Both acute bouts of exercise 
and long-term exercise training have been shown to alter Sal-IgA levels. From 
an immunological protection perspective, exercise can be potentially beneficial 
by increasing Sal-IgA, neutral by having little effect on Sal-IgA, or detrimental 
by decreasing Sal-IgA secretion. Different intensities of exercise have been 
shown to have each of these effects on Sal-IgA [5, 21]. A single bout of aerobic 
exercise usually has a short-term effect on Sal-IgA concentration, altering both 
IgA secretion rate and saliva flow rate.  
 
What are the effects of exercise intensity on Sal-IgA? 
 
Both the direction and magnitude of Sal-IgA responses to exercise appear 
to be intensity dependent. High intensity exercise can lead to a decrease in Sal-
IgA secretion, which may be observed immediately following exercise and may 
be sustained for some hours after the exercise [13]. Conversely, moderate 
intensity exercise, for example at 50-60% of VO2max, may increase Sal-IgA 
secretion. The magnitude of changes observed may depend on the relative 
intensity, the duration of the exercise, the training status of the subjects, and 
whether the change in Sal-IgA is reported as a concentration, concentration 
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relative to salivary composition changes such as albumin concentration or 
osmolality, or as a secretion rate, and have been reviewed previously [15, 16].  
 
Few studies have compared the effect of exercise intensity on the response 
to exercise in the same subjects. Williams et al. [21] found that a short bout of 
cycling exercise at a moderate intensity (50% VO2max) increased Sal-IgA in 
young adults whereas cycling exercise at 70% VO2max and performing a VO2max 
test led to progressively greater decreases in Sal-IgA immediately post-exercise. 
Dorrington et al. [5] found similar patterns of Sal-IgA in response to cycling at 
different intensities in children.  
 
What are the effects of aerobic fitness level on Sal-IgA? 
 
Dorrington et al. [5] compared the Sal-IgA responses to cycling in children 
with lower and higher aerobic fitness levels. There were no differences between 
fitness groups in the Sal-IgA responses to high intensity exercise, but the 
children with higher aerobic fitness levels had greater increases in Sal-IgA in 
response to moderate intensity exercise at 50% VO2peak. The difference in 
responses was considerable with the less fit children exhibiting a 25% increase 
in Sal-IgA compared to a 65% increase in children with greater aerobic fitness. 
This suggests that the possible benefits of stimulating increases in Sal-IgA with 
moderate intensity exercise are fitness level dependent. It is also possible that 
the relative intensity that optimally stimulates IgA may differ with aerobic 
fitness level. 
 
One explanation for the observed variation in the pattern of Sal-IgA 
responses to exercise of similar relative intensity among studies is differences in 
training status (EIR), and aerobic fitness level may be one characteristic that 
differs among these populations [16]. 
 
What are the effects of exercise training on Sal-IgA? 
 
Many studies have reported Sal-IgA responses to training periods of 
varying durations, and in many of these studies the training loads were well 
tolerated and Sal-IgA levels were well maintained or even increased. Repeated 
days or weeks of high intensity exercise training sessions, particularly if the 
training volume is large or combined with intense competition appear to 
increase an athlete’s vulnerability to reductions in Sal-IgA. This pattern of 
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training is much more likely in high performance or elite athletes than in 
recreational exercisers. Therefore, vulnerability to adverse immune 
consequences of exercise training has largely been explored in this context. 
Decreases in IgA over a training season have been observed in elite swimmers 
[11]. Changes in IgA have been reported to vary with training load in sprinters 
and jumpers with decreases in IgA during a high intensity training cycle 
followed by an increase in IgA during a recovery phase. 
 
We recently observed a gradual decline in pre-game IgA levels across a 
season in elite Rugby League players (unpublished data). The lowest pre-game 
levels were observed mid-season and preceded a marked increase in reports of 
URTI. The lower IgA levels may have increased the risk of developing these 
illnesses. Rugby League players are frequently exposed to pathogens by visitors 
to the locker room after games when they may be particularly vulnerable to 
infections due to reduced post-game levels of IgA. 
 
Multiple intense training sessions in a day have been shown to impair Sal-
IgA recovery such that an athlete commences a subsequent session with 
reduced Sal-IgA levels [13]. The immunosuppression is compounded if this 
training pattern is repeated on subsequent days, as was demonstrated in the case 
study of an elite kayaker performing 2-4 exercise session per day. 
 
Are Sal-IgA measurements and responses to exercise reliable? 
 
Common observations in studies of Sal-IgA and exercise are the variability 
in the response patterns and values obtained. This has raised questions about 
the sources of variability and repeatability of Sal-IgA measurements. Francis et 
al. [6] found substantial biological variability in Sal-IgA levels between 
individuals and within an individual, which has important implications for 
monitoring Sal-IgA in athletes and for the design of research studies. To 
observe statistically significant differences, the subject numbers may need to be 
higher in studies of elite athletes than non-elite exercisers, and non-elite 
exercisers or sedentary populations may not necessarily form appropriate 
control subjects for studies of immune function in elite athletes due to 
differences in variance between populations. However, Sal-IgA responses to 
exercise do appear repeatable under controlled laboratory conditions [2] in 
healthy athletes. This is good news for studies of Sal-IgA responses to exercise 
in groups of athletes as it provides confidence in the results obtained and the 
 13 
conclusions drawn.  
 
Do we know when a change in Sal-IgA is relevant? 
 
Reductions in Sal-IgA alter the risk of infections such as URTI, but exposure 
to a pathogen is also necessary before there is a consequence of reduced Sal-
IgA secretion. Vulnerability to URTI increases with the level of Sal-IgA 
concentration decreases, and chronically low Sal-IgA levels increase the risk of 
URTI substantially. Gleeson et al. [11] observed this increasing vulnerability in 
elite swimmers. A progressive increase in infection risk was directly 
proportional to the decrease in Sal-IgA level. 
 
Is there an established critical level of Sal-IgA? 
 
Defining a precise concentration of Sal-IgA below which risk clearly 
increases for all individuals has not yet been established. This is extremely 
difficult due to the substantial biological variability in Sal-IgA levels observed in 
some individuals. The daily variability in the values obtained from an individual 
varies between athletic populations, and may be greater in more elite athletes 
[6]. These findings mean that regular monitoring is required to establish the 
normal and vulnerable Sal-IgA ranges for an individual athlete, and that more 
extensive monitoring may be required to establish these ranges in elite athletes 
than less highly trained individuals. Consequently Sal-IgA monitoring may not 
be logistically or financially feasible with currently available methodologies.  
 
What do we know that is useful about Sal-IgA? 
 
We know that athletes are more likely to experience decreases in Sal-IgA 
levels following high training loads and that exposure to a pathogen while 
vulnerable increases the risk of developing an illness. The consequence of these 
two factors is observed in illness clusters such as has been reported in 
swimmers at competitions [19]. As mentioned earlier, team athletes with 
decreasing Sal-IgA levels as the season progresses combined with increased 
exposure to pathogens during travel or in the locker room after games may 
result in a cluster of illness reports. Consequently, monitoring training loads at 
key times or in individuals susceptible to recurrent infections, combined with 
strategies to minimize exposure to pathogens, may be the most cost-effective 
strategies to prevent frequent or untimely bouts of URTI or other infectious 
illnesses in athletes. 
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Does it affect performance? 
 
Performance is not necessarily compromised in athletes who report upper 
respiratory symptoms [18, 19]. Training volume and intensity may be reduced 
when athletes are experiencing symptoms as observed in runners reporting 
upper respiratory illness [18], but minimal differences in performance measures 
such as maximal oxygen uptake, running economy, and time to exhaustion were 
observed in this cohort. Pyne et al. [18] found the impact of mild upper 
respiratory illness on international performance in swimmers to be variable, 
with trivial effect on performance in some swimmers, substantial detrimental 
effects in some, and surprisingly, beneficial effects in a small number of 
swimmers. 
 
When is monitoring Salivary IgA relevant to individual athletes? 
 
The athletes who are most likely to benefit from Sal-IgA monitoring are 
those who suffer from recurrent URTI, regularly present with URT symptoms, 
or report unresolved fatigue. Repetitive high intensity training has been shown 
to decrease Sal-IgA levels and contribute to the recurrent bouts of URTI in a 
swimmer over a season [10] whereas appropriate rest allowed an increase in Sal-
IgA and a reduction in bouts of URTI. Reductions in Sal-IgA have been shown 
to precede reactivation of EBV associated with upper respiratory symptoms 
[14]. Athletes who suffer recurrent fatigue should be investigated for Herpes 
group viral reactivation, and Sal-IgA monitoring may be useful in establishing 
appropriate training loads on resumption of training. 
 
It takes time to develop an effective monitoring program for an athlete. It 
requires sufficient monitoring to establish a personal critical Sal-IgA level for 
the individual athlete, ongoing monitoring of pre-training Sal-IgA, and 
monitoring Sal-IgA responses to normal training sessions. Periods of increased 
risk of URTI need to be identified and a willingness to modify training 
accordingly is essential. Also it requires timely assaying of the saliva samples 
collected such that modifications to training to can be introduced before the 
health of the athlete is further compromised. 
 
Can Salivary IgA levels be increased in at-risk athletes? 
 
A number of interventions have been proposed to increase (restore) Sal-
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IgA levels to a low risk level. A typical recommendation is to first reduce or 
eliminate sources of both physical and psychological stressors [17]. This may 
include modifying training by decreasing intensity, eliminating sessions or 
increasing rest days. Psychological issues that have an impact of Sal-IgA 
suppression, whether related to training or not, need to be addressed. Financial 
or work-related stress as well as problems in personal relationships may be 
important but more difficult to address than training. Dietary interventions may 
have a role [9, 12]. Whether the athlete’s regular diet is appropriate in terms of 
both energy and other nutrients [8] or whether specific dietary interventions 
such as increased carbohydrate intake [12], caffeine [1], and possibly probiotics 
[3] are beneficial are not yet clear but promising possibilities. Pharmacological 
interventions such as antivirals are only justified with a confirmed diagnosis 
against which the therapeutic agent is known to be effective [4]. 
 
What medical conditions are associated with long-term fatigue 
and poor performance in athletes? 
 
Reid et al. [20] investigated long-term fatigue in athletes and found that this 
fatigue and the associated poor performance were a consequence of 
undiagnosed or poorly controlled disease states. A number of the athletes 
investigated suffered recurrent infections, which were primarily due to CMV 
and EBV; 47% of those with recurrent infections had IgG3 suppression. The 
other most common conditions were asthma (37%) and allergy (32%). Early 
studies suggest there may be a role for probiotics in athletes experiencing 
recurrent fatigue and poor performance[3]. 
 
Conclusions 
 
Sal-IgA monitoring can be a valuable tool in the management of athletes 
experiencing ongoing fatigue and/or recurrent infections, particularly URTI. 
Routine measurement of Sal-IgA in asymptomatic athletes may not be practical 
either logistically or financially. Sal-IgA measurement can be an effective tool 
for evaluating the impact of different types of exercise and exercise training on 
URTI risk in different exercising populations, but care should be taken in the 
determination of participant numbers and the choice of control groups for such 
studies as Sal-IgA concentrations vary substantially within and among 
individuals and different sporting populations. A number of interventions have 
been proposed to increase Sal-IgA secretion, but their effectiveness at reducing 
URTI risk remains to be established. 
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Abstract 
 
Exercise-induced suppression of certain immune functions during 
strenuous training periods, increased exposure to foreign pathogens while 
travelling, as well as sharing the same training- and living facilities within a team 
may put athletes at increased risk of infections. Preventive measures are the first 
and foremost tasks to implement, to avoid disruption of crucial training and 
competition schedules. However, when signs of respiratory tract infections 
(RTI) appear in individual athletes or among members of athletic teams, fast 
and proper management is paramount to limit the disruption of training and 
performance capacity. A short review of clinical manifestations, diagnosis and 
proper management of both upper and lower respiratory tract infections is 
given in the first section. Mononucleosis among athletes is briefly discussed and 
some general guidelines for management of the return to regular training during 
the convalescence phase of this particular infection are given. This is most 
pertinent to health professionals dealing with athletes with infections. The 
second section outlines guidelines with respect to prevention of RTI as well as 
management strategies when athletes are suffering from RTI. At the end, 
practical guidelines for safe return to normal a training schedule are 
summarized, aiming primarily at coaches and athletes.   
 
 
Introduction 
 
Athletes performing at high levels in their sports are most often members 
of a selected group of people that are able to withstand the stress imposed from 
strenuous training and competition schedules without major illnesses and 
prolonged periods of fatigue (Gleeson, 2000;Nieman, 2000;Ronsen et al., 2001). 
Nevertheless several studies suggest that athletes are at increased risk of 
respiratory tract infections (RTI)(Gleeson, 2000;Nieman et al., 1989;Nieman et 
al., 1990;Peters, 1997). Exercise-induced suppression of certain immune 
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functions during strenuous training periods, increased exposure to foreign 
pathogens (microbes) while travelling, as well as sharing the same training- and 
living facilities within a team may contribute to this increased frequency or 
duration of RTI (Gleeson, 2000). Obviously, some sort of microbe (virus, 
bacteria, fungus, etc.) must be transmitted to the body at a certain time point 
and have the ability to invade the respiratory tract for an RTI to occur. 
However, several environmental and physiological circumstances such as heat 
and cold exposure, psychological stress, nutritional status, and training load are 
known to modulate the body’s response to such pathogens and thus increase or 
decrease the course of the infection(Pedersen et al., 1994). 
 
 A recent survey among 74 Norwegian athletes participating in the 2002 
Olympic Winter Games and the 2004 Olympic Summer Games showed that 
more than 90% of the athletes reported one ore more infectious episodes 
during a year (data presented at ISEI congress 2005). Respiratory tract 
infections and gastroenteritis were the most common diseases reported and the 
duration of symptoms was mostly within 1 week. However, since many suffered 
several infectious episodes through a year, the average number of lost training 
days was 15 per year. Frequent absence from vital training sessions is highly 
undesirable for both athletes and coaches and will most likely have a negative 
impact on the performance level during parts of the season. The study also 
showed that on the average one important competition per year was lost due to 
illness. Finally, there was a large degree of variability in the frequency and 
duration of infectious diseases reported by the athletes, with some never being 
sick while others missed more than 30 days/year of scheduled training due to 
illness. This of course sets the stage for important preventive measures among 
the most illness susceptible athletes.     
 
Prevention is always preferable and superior to treatment, even the best 
sports medicine based treatment. Therefore, all means and methods to avoid 
unnecessary and unprotected exposure to virus, bacteria should be practiced in 
athletic settings in order to avoid loss of training and competitions to episodes 
of infections (Ronsen, 2003). Consequently, athletes and coaches need to be 
educated and guided with regard to important preventive measures on how to 
avoid infectious diseases. However, all contact with unknown sources of 
microbes is unavoidable in a normal life style of an athlete. This makes the 
correct management of infectious illnesses of paramount importance in order to 
limit the negative consequences of the infection. Management of RTI from a 
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physician standpoint should always be based on a thorough medical history, an 
evaluation of clinical signs and symptoms, a skilled physical examination and a 
specific microbial diagnosis. The first section in this chapter outlines the basics 
in detection and management of RTI, aiming at the medical personnel dealing 
with athletes. This part contains mostly text-book material  as well as review 
articles and is thus not specifically referenced (Dasaraju P.V and Lui C., 
1996;Gleeson et al., 2004;Nieman, 1998;Nieman, 2000;Weidner, 1994). The 
second section outlines practical guidelines with respect to the management and 
prevention of RTI, aiming primarily at coaches and athletes. The information 
here is based on a mixture of personal clinical experience from 12 years of 
providing medical care to Olympic athletes as well as well established 
knowledge in the field of infectious medicine.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Location of upper and lower respiratory tract infections. 
 
 
Physician-based management of RTI 
 
Upper Respiratory Infections: Common Cold, Otitis, Sinusitis, 
Pharyngitis, Epiglottitis and Laryngotracheitis. 
 
Etiology and Pathogenesis: Most upper respiratory infections are caused 
by virus. In some cases, bacteria like Haemophilus influenzae type b and 
Streptococcus pyogenes may be the primary cause of infection (sinusitis, 
tonsillitis, epiglottitis and laryngotracheitis/croup). An episode of viral infection 
may also progress into a bacterial infection in certain locations of the respiratory 
Sinusitis 
Pharyngitis 
Tonsillitis 
Epiglotitis 
Laryngitis 
 
Bronchitis 
Bronchiolitis 
Pnemonia 
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system. The micro-organisms enter the respiratory tract by inhalation of 
droplets and invade the mucosa, resulting in epithelial destruction with redness, 
edema and exudate. 
Clinical manifestations and Diagnosis: Initial symptoms of a common 
cold are runny, congested nose, sneezing, and/or a soar throat. Fever and 
general feeling of malaise may or may not acompany these initial symptoms. 
Common colds typically have mild to moderate symptoms with duration of 
approximately 4-7 days. Sinusitis is usually characterized by pressure pain in the 
forhead or maxillary bone(s) in addition to the symptoms mentioned above. 
Infections in the middle ear (otitis media) usually presents with pressure-pain 
in/around the ear(s) in addition to fever and stuffy nose and are mostly seen in 
children. Bacterial pharyngitis/tonsillitis most often starts with high fever, 
glandular hypertrophy and a painfull throat. Upon inspection the tonsils are 
enlarged, inflamed and often covered with purulent secretion. Epiglottitis and 
laryngotracheitis (croup) may also cause difficulties with breathing, but are most 
common in children. Different strains of influenza virus appears during 
seasonal epidemics and is usually diagnosed on the basis of clinical 
manifestations such as high fever, severe feeling of malaise, myalgia and 
headache.  
Bacterial and viral cultures of throat swab specimens or nasal discharge are 
used for diagnosing pharyngitis, sinusitis, epiglottitis and laryngotracheitis. 
Specific quick-tests (Enzyme-linked immunoassay methods) for diagnosing 
infections by Streptococcus type A are commercially available. A rise in the C-
reactive protein (CRP) to values between 10-50 mg/L may indicate a viral 
infection, while bacterial infections most often result in CRP values above 50 
mg/L. However, these are general guidelines and must be evaluated along with 
clinical manifestations of an infection. Blood cultures or serological antibody 
titres may be helpful in obtained a microbiological diagnosis in cases of severe 
or longstanding infections. A CT or MRI scan of the paranasal/cranial sinuses 
may be helpful in the diagnosis of recurrent or chronic sinusitis.  
It is wise to remember that several of the clinical manifestations 
characteristic for bacterial tonsillitis and pharyngitis are similar to the debut of 
mononucleosis, an infection caused by the Epstein Bar virus. However, 
mononucleosis is a systemic infection that affects lymphatic glands in most of 
the body, the liver and spleen, and often causes prolonged high fever, lethargy, 
swelling of the lymphatic nodes and organs, in addition to the symptoms of 
throat infection. When it coincides with a bacterial tonsillitis/pharyngitis, 
proper antibacterial therapy should be administered even though antibiotics do 
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not affect the EB viral infection. If strenuous physical exercise is performed 
during the initial or convalescence phase of mononucleosis, this may lead to 
increased morbidity (worsening of the clinical manifestations) and/or relapse 
with a more prolonged recovery period(Sevier, 1994). Therefore, it is essential 
to recognize this infection at an early stage with specific Enzyme-linked 
immunoassay tests and/or serologic detections of specific antigens and/or 
antibodies to the Epstein Bar virus. The clinical manifestation of 
mononucleosis may be mild in childhood and thus not specifically recognized 
and diagnosed. However, when it appears in adolescence or adults, the 
symptoms are usually much more severe and long standing with higher risks of 
relapses during the convalescence period.  
With respect to return to exercise and sports participation, it is important 
that the physician and the athlete use an individual approach based on the 
improvement of symptoms, clinical sign and lab results (Dommerby et al., 
1986;Sevier, 1994). However, some general guidelines may be helpful to the 
physician and athlete in this process. 
 
Guidelines for return to exercise after mononucleosis 
 
1. Before starting light exercise (brisk walking, easy cycling, light resistance 
training etc), have 5-7 days without febrile episodes and lethargy or 
other systemic symptoms. 
2. Ensure a substantial decrease in EB antibody titre and liver enzymes 
(ALAT, ASAT) 
3. Limit the exercise sessions to 20-30 min every other day for the first 
week with a low intensity (puls rate<120 bpm) 
4. Avoid exercises modes may cause increased pressure or pounding to the 
abdomen  
5. Observe the tolerance to each exercise session and during the recovery 
day thereafter. 
6. Discontinue the exercise if relapse or worsening of earlier symptoms 
7. Consult with your physician before commencing exercise again  
8. If acceptable tolerance to first week of exercise, continue the next week 
with 30-45 min sessions every other day with a moderate intensity (puls 
rate<140 bpm). 
9. Have your physician perform a clinical exam and lab assessment before 
progressing towards further normalization of your training schedule. 
10. Exclude the possibility of hepatosplenomegalia (enlarged liver and 
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spleen) in those athletes returning to contact sport by an ultrasound or 
CT scan of the upper abdomen. 
11. Always respect signs and symptoms of relapse and/or intolerance to a 
progressing exercise load and consult with your physician about 
continuing exercise or not.    
 
Treatment: Common viral infections of the upper respiratory tract are 
treated symptomatically and include such measures as nasal washings with 
sodium cloride, nasal decongestions (beware of possible banned substances for 
athletes), non-steroidal anti-inflammatory drugs, paracetamol, acetaminophen, 
or other analgesics. The main strategy is to facilitate drainage of excessive 
exudate from the mucosa of the upper airways and prevent stagnation of 
infected exudate in sinuses, nasopharynx and ear. A purulent sinusitis will in 
most cases be successfully treated with a beta-lactamase resistant antibiotic such 
as amoxicillin or a cephalosporin for 10-14 days and pharyngitis/tonsillitis with 
beta-hemolytic streptococci should be treated with Penicillin G for the same amount 
of days. Other bacterial infections should be treated with proper antibiotics, in 
accordance with the results of a good clinical evaluation and microbiological 
diagnosis. Epiglottitis and laryngotracheitis (croup) that results in major 
breathing problems (stridor and cyanosis) must be treated immediately with 
proper medication facilitating airway expansion, preferably in hospitals. 
Epiglottitis caused by Hemophilus influenzae bacteria needs to be treated with 
antibiotics. Surgical treatment should be considered in cases of recurrent 
bacterial tonsillitis and chronic sinusitis.  
Vaccine against Haemophilus influenzae type b infections and  specific 
seasonal influenza viruses are commercially available. The influenza vaccine is 
altered each year according to the change in seasonal epidemics around the 
world, and thus needs to be taken each year to acquire specific immunization. 
The need for such vaccines is questionable for healthy people but may be 
considered in athletes prone to recurrent or prolonged infections during a 
season with multiple competitions.  
 
Lower Respiratory Infections: Bronchitis, Bronchiolitis and 
Pneumonia. 
 
Etiology and Pathogenesis Lower respiratory infections may be viral or 
bacterial. Viruses cause most cases of bronchitis and bronchiolitis. In 
community-acquired pneumonias, the most common bacterial agent is 
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Streptococcus pneumoniae. Atypical pneumonias are cause by such agents as 
Mycoplasma pneumoniae, Chlamydia pneumoniae and viruses. Organisms enter the 
distal airway by inhalation, aspiration of gastric content or by hematogenous 
seeding. The pathogen multiplies in or on the epithelium, causing inflammation, 
increased mucus secretion, impaired mucociliary function which may lead to 
airway obstruction. 
 
Clinical Manifestations and Diagnosis: Lower respiratory infections are 
usually characterized by cough, sputum production, shortness of breath and/or 
tachypnea, fever, generalized malaise, and/or chest pain. Patients with 
pneumonia and bronchopneumonia may also exhibit non-respiratory symptoms 
such as, headache, myalgia, nausea and abdominal pain. 
Auscultation of the lungs often reveal a characteristic crepitating sound or 
reduced ventilation in localized (lobar pneumonia) or more generalized 
(bronchopneumonia) areas. A two-way chest X-ray may be helpful in 
differentiating between pneumonia, bronchopneumonia and other causes of 
persistent cough and lower airway symptoms. A differential count of white 
blood cells and measurement of CRP may be helpful in the initial assessment of 
respiratory infections. However a specific microbial diagnosis requires a 
specimen from sputum or nasal discharge to be cultured for bacteria, fungi and 
viruses. Blood cultures and/or serologic detections of antigens and antibodies 
can also be used to identify several micro-organisms. Enzyme-linked 
immunoassay methods and detection of nucleotide fragments specific for the 
microbial antigen in question by DNA probe or polymerase chain reaction can 
offer a rapid diagnosis.  
 
Treatment: Symptomatic treatment is used for most viral infections of the 
lower respiratory tract. Couch-reducing medications should for the most part be 
restricted to conditions of dry, non-productive coughing, and athletes must be 
careful not to use medications with banned substances. The inflammatory 
reaction during an acute episode of bronchitis may lead to temporary 
constriction of the bronchial airways and ventilatory obstruction (asthma). Such 
conditions need to be properly diagnosed and treated with bronchio-dilatory 
medications and inhalation steroids. Bacterial bronchitis and pneumonias are 
treated with antibiotics, according to the identification of a specific micro-
organism and its sensitivity/resistance pattern to selected antibiotics.  
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Athlete-based prevention and management of RTI  
 
There is no single method or measure that completely eliminates the risk of 
contracting a RTI, but there are several effective ways of reducing the number 
of infectious episodes incurred over a period. Some of these measures are 
scientifically founded while others are supported mostly by clinical and personal 
experience. In essence, it is all about avoiding transmission of microbes from 
one person to another! It is important to underline that virus and bacteria 
causing RTI may be both received by and passed on from the same individual. This 
means that one should pay as much attention to preventing transmission of 
potentially contagious material from oneself to others as the opposite way, from others 
to oneself. Therefore, the overall “golden rule” of practicing the same standard of 
hygiene when you are in contact with others as you expect others to practice 
towards you, should be the general objective of RTI prevention. A list of the 
most common preventive measures and practical guidelines against RTI 
infections, but also against any contagious disease, is given in the following 
guidelines.  
 
Guidelines for prevention of infections among athletes 
 
1. Make sure that you are updated on all vaccines needed at home and for 
travels  
2. Minimize contacts with infected/sick people, animals and contagious 
objects  
3. Keep at distance to people who are coughing, sneezing or having a 
“runny nose” 
4. Wash hands regularly, before meals, and after direct contact with 
potentially contagious people, animals, blood, secretions, public places, 
bathrooms, etc.  
5. Use disposable paper towels and limit hand to mouth/nose contact 
when suffering from RTI symptoms 
6. Quickly isolate a team member with RTI symptoms and move out 
his/her roommate 
7. Check air condition/ventilation systems for potential contagious 
material  
8. Do not use other peoples drinking bottle, cups, silverware, etc 
9. Wear proper out-door clothing and avoid getting cold and wet after 
exercise  
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10. Protect upper and lower airways from being directly exposed to cold 
and dry air during strenuous exercise, by using facial mask etc. at 
temperatures below -15oC 
11. Practice good recovery routines, including proper nutrition and re-
hydration 
 
Even if meticulously practicing all the important preventive measures that 
athletes, coaches and medical support staff can put up against respiratory tract 
infections, it is everybody’s experience that RTI, nevertheless, takes its toll, both 
on individual athletes and in teams.  Therefore, it is crucial that all episodes of 
RTI including the initial symptomatic phase are well managed and that the 
spread of microbes between members of a team of family is limited. For 
athletes on a training schedule the obvious question when initial symptoms of 
RTI appears is about continuing, decreasing or stopping their regular exercise 
training.  
 
The athletes themselves must make the first assessment on these matters 
and then consult with a physician to make clinically based decision for each 
individual athlete. Nevertheless, some general “rules of thumb” may be offered 
to guide the athlete and his support team to make the best choices on if and how 
exercise should be continued through an infectious episode. The guidelines are 
summarized bellow.  
 
 
Guidelines regarding exercise during episodes of RTI in 
athletes 
 
First day of illness: 
 
 Drop strenuous exercise or competitions when experiencing RTI 
symptoms like  
 Sore throat or coughing 
 Runny or congested nose 
 Drop all exercise when experiencing additional RTI symptoms like  
 Muscle/joint pain and headache   
 Fever and generalized feeling of malaise 
  
 Drink plenty of fluids, keep from getting wet and cold, and 
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minimize life-stress 
 Consider use of topical therapy with nasal drainage, decongestants 
and analgesics if fever  
 Report illness to a team physician or health care personnel and keep 
away from other athletes if you are part of a team training or 
travelling together 
 
Second day: 
 
 If you have fever (temp >37,5-38oC) or increased coughing : No 
training !! 
 If no fever or malaise and no worsening of “above the collar”-
symptoms: Light exercise (pulse < 120bpm) for 30-45 min, indoor 
during winter and by yourself  
Third day 
 If still fever and RTI symptoms: Consult your (team) physician by 
phone or at office  
 If no fever or malaise and no worsening of initial symptoms: Moderate 
exercise (pulse < 150bpm) for 45-60 min, preferably indoor and by 
yourself  
 
 
Forth day: 
 If no symptom relief: Do not try to exercise but make an office visit to 
your doctor 
 If first day of improved condition: Follow the guidelines of 
“return to exercise” below : 
 
 
 
In a similar fashion, and with the same constraint of not substituting these 
guidelines for physician based individual advises, further strategies for safe and 
healthy return to regular a training schedule is given bellow. It must be 
emphasized that the author is not responsible for the individual medical 
outcome of adhering to these guidelines. 
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Guidelines for return to normal training after respiratory tract 
infections 
 
1. Make sure that you have one day without fever and with improvement 
of RTI symptoms before returning to exercise.    
2. Observe the body’s reaction to your first exercise session before 
starting on a new session. 
3. Stop physical exercise and consult you physician if  
 New episode with fever or worsening of initial symptoms 
 Persistent coughing and exercise-induced breathing problem  
4. Use the same number of days to step up to normal training as spent 
off regular training because of illness. 
5. Observe closely your tolerance to increased exercise intensity and take 
an extra day off if you do not recovering satisfactory.   
6. Use proper outdoor clothing and specific cold air protection for 
airways when exercising in temperature below –10oC the first week 
after RTI 
 
 
Summary 
 
Although regular exercise seems to have a stimulatory effect on the 
immune system and thus may decrease the risk of respiratory tract infections, 
both personal experience as well as some scientific evidence support the 
contention that athletes may be at increased risk of RTI during periods of 
intense training and competition schedules. Several factors may explain this 
phenomenon, including training-induced immune suppression, increased 
exposure to foreign microbes while travelling, as well as sharing of training- and 
living facilities which increases the exposure as well as the transmission of 
pathogens. Most of the common microbes that cause RTI are relatively 
harmless for healthy people perhaps with exception of the Epstein Bar virus 
that causes mononucleosis. Nevertheless, if extreme environmental factors, 
stress and strenuous training schedules are imposed on a person that have 
contracted a respiratory infection, this may result in significant aggravation and 
protraction of the symptoms and physiological disturbances in the body. Thus, 
immediate diagnostic assessment and patient management is imperative to 
reduce the negative consequences on the health as well as on the performance 
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level of the athlete. However, the most effective way of fighting respiratory 
tract infection for an athlete may be to apply common-sense preventive 
measures against transmission of contagious material in his/her environment 
and life style.         
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I. General aspects of asthma  
 
Asthma is currently defined as a “chronic inflammatory disease of the 
airways in which many cells and cellular elements play a role. The chronic 
inflammation is associated with airway hyperresponsiveness that leads to 
recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, 
particularly at night or in the early morning. These episodes are usually 
associated with widespread, but variable, airflow obstruction within the lung 
that is often reversible either spontaneously or with treatment”.  
 
The prevalence of asthma has been increasing over the past 30 years, as can 
be seen in TableI. 
 
Table I - Rising prevalence of allergic asthma 
Country Ages Years 
of study 
Prevalence 
Austrália 8 - 10 1982 and 
1992 
7   11% 
Escócia 8 - 13 1964 and 
1989 
4   10% 
Gales 12 1973 and 
1988 
4   9% 
Austrália Adults 1981 and 
1990 
9   16% 
 
 
Asthmatic patients can have varying degrees of asthma severity. Pre-
treatment asthma severity is classified according to clinical criteria and lung 
function testing into intermittent or persistent. The latter is subdivided into 
mild, moderate and severe (Global Initiative for Asthma Guidelines). 
Most people with asthma have symptoms when exposed to various factors 
(namely physical exercise). However, some asthmatic patients only have 
symptoms when they perform physical exercise. This is known as Exercise-
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Induced Asthma (EIA). 
Currently, exercise-induced asthma is regarded as a form of intermittent 
asthma. 
 
Types of asthma 
 
Depending on triggers, asthma can be subdivided into: a) intrinsic or non-
allergic asthma, and b) extrinsic or allergic asthma. Extrinsic asthma is the more 
common form and is more frequently observed in younger patients. In contrast, 
intrinsic asthma is more frequent in older patients. Environmental allergens are 
the triggers for allergic asthma and various non-allergic factors may be the 
triggers for non-allergic asthma. In both cases, non-specific factors such as 
colds, inhalation of cold air, etc, may also act as inducers of asthma symptoms. 
 
Immunopathophysiology of bronchial asthma 
 
When an allergen a person is sensitised to (allergic to) reaches the bronchi, 
it binds IgE molecules that are specific for it and which are bound to high 
affinity receptors (FcεRI) on the cellular membrane of cells such as mast cells 
which are located in the mucosa. Cross-linking of FcεRI-bound IgE molecules 
by the allergen activates mast cells and induces an extensive degranulation of 
cytoplasmic granules. These granules are rich in various substances (e.g. 
histamine, tryptase, etc.) that are crucial for the development of acute-onset 
asthma symptoms. In addition, this process also initiates the synthesis of 
arachidonic acid-derived molecules (leucotrienes, prostaglandins) in the mast 
cells. These lipid mediators contribute towards several deleterious aspects of 
bronchial asthma such as bronchoconstriction, bronchial vasodilatation, 
increased mucus production, etc. 
However, apart from these mechanisms related to the immediate effects of 
exposure to allergens, one must also take into consideration that an allergen is a 
protein. In fact, as an external protein, allergens are endocytosed by cells that 
are resident in the bronchi, particularly dendritic cells (or B lymphocytes). 
Dendritic cells process the ingested allergen and present the allergen-derived 
peptides to T lymphocytes, in the context of MHC class II molecules. In case 
such antigen presentation is correct, T cells become activated, proliferate and 
start producing high levels of cytokines. In allergic patients, allergen-specific T 
cells are biased towards producing an unbalanced pattern of cytokine 
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production known as a Th2-type pattern. This pattern involves the production 
of high levels of interleukin (IL)-4, IL-5, and IL-IL-13 as well as low levels of 
IFN-γ. Such cytokine pattern contributes towards the development and 
maintenance of allergic responses because IL-4 and IL-13 induce isotype 
switching to IgE in B lymphocytes, and IL-5 stimulates the influx, activation 
and resistance to apoptosis in eosinophils. It should be remembered that high 
IgE levels and eosinophilia are the hallmarks of allergic disease. IgE synthesised 
by B cells will then be free to bind FcεRI on mast cells, thereby being ready for 
further interaction with the relevant allergen. The aspects related to the allergen 
as a protein are associated with the maintenance of chronic, ongoing, allergic 
inflammation in the bronchi (Figure 1). 
 
 
Figure 1. Immunopathology of early and late-phase (chronic) inflammation 
in asthma. 
 
Clinical symptoms of bronchial asthma 
 
The most frequent asthma symptoms observed in asthmatic symptoms are: 
- persistent dry cough 
- shortness of breath (dyspnoea) 
- wheezing 
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- chest tightness 
 
These symptoms generally occur in association. However, they may also 
arise independently. In fact, some asthmatic patients only have chronic dry 
cough, particularly at night. 
 
Lung function in bronchial asthma 
 
Due to the presence of bronchial obstruction, which may be more or less 
generalized, asthma modifies respiratory physiology in mainly two ways: 
 
 a) an increase in expiratory pressure; 
 b) an increase in air trapped in the bronchi. 
 
 
Treatment of bronchial asthma 
 
Asthma treatment involves basically two types of inhaled drugs (although oral 
medication may also be necessary):  
a) those that inhibit or reverse bronchial constriction; and  
b) anti-inflammatory drugs.  
 
β2-agonists (salbutamol, terbutaline, formoterol, salmeterol) belong to the 
first type of drug. These drugs relieve acute symptoms and relax the bronchial 
muscle. On the other hand, anti-inflammatory drugs such as corticosteroids 
(such as beclomethasone, budesonide or fluticasone) act as preventive 
medicines, are crucial for inhibiting bronchial inflammation and are crucial for 
reducing chronic asthma symptoms. 
 
Bronchial asthma and Physical Exercise 
 
In asthmatic patients, physical exercise may help with respiratory 
physiology, although it may also trigger asthma symptoms. Exercise-induced 
asthma is frequent in patients with bronchial asthma (Table II). 
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Table II – Prevalence of exercise-induced asthma 
 
 
 
II. Exercise-induced asthma  
 
Asthma symptoms induced by physical exercise (EIA) are more frequent in 
cold and dry environments. EIA generally arises a few minutes (> 5 min) upon 
having stopped physical exercise, although, more rarely, it may also start during 
the exercise itself. Curiously, EIA-related symptoms are followed by a refractory 
period of several hours, during which asthmatic patients may potentially engage 
in physical activities without developing asthma symptoms. However, if 
symptoms were more severe, care should be taken in deciding how soon after 
an asthma attack can an athlete or PE student return to practising exercise. 
 
 
Pathophysiology of Exercise-Induced Asthma 
 
In general, non-asthmatic individuals appear to have maximally dilated 
airways at rest and, thus, have little change associated with exercise, at least 
during short duration exercise (< 15 minutes). Potent bronchodilating 
influences are in operation during physical exercise. In fact, physical exercise 
has been shown by various studies to improve airway calibre in asthmatic 
individuals when the exercise lasts less than 15 minutes. In contrast, there is 
generally a decline in pulmonary function over time during exercise in asthmatic 
individuals, after the initial bronchodilation. This may, at least in part, have to 
do with the fact that when performing physical exercise, breathing rate 
Country (Year) Sample Methodology Prevalence 
Malaysia (2001) Schoolchildren Questionnaire 8% (NC) 
50% (BA) 
USA (1998) Military recruits Prova de esforço 7% 
USA (2001) Elite athletes Questionnaire 
(“self-report”) 
and LFT 
29% (Q) 
26% (LFT) 
Kenya (1998) Children and 
adolescents 
Questionnaire 
(parents) and LFT 
23% (city) 
13% (rural) 
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increases. Apart from allowing a greater intake of eventually noxious, irritating 
environmental substances such as some types of pollutants or allergens, an 
increased breathing rate also implies that inhaled air has less time to be 
conditioned and warmed by the upper airways. It is therefore thought that two 
types of effects may contribute towards the development of asthma symptoms 
while exercising: a) a decrease in temperature in the bronchial mucosa, due to a 
lower degree of warming of inhaled air; b) an increased dehydration of the 
bronchial mucosa, due to a more rapid passage of air through the nose which is, 
therefore, less humidified. Whichever of these two mechanisms is the more 
relevant is debatable. Both may, in fact, be involved. Nevertheless, the most 
important fact is that either may lead to the stimulation of nervous endings in 
the bronchi and to the induction of a local cellular influx. These two events will 
be associated with bronchial constriction and inflammation. 
 
Types of physical exercise and EIA 
 
Although, potentially, all types of physical exercise may induce asthma, 
some are more “asthmogenic” than others. For example, in the context of 
anaerobic exercise, athletics more often induces EIA than swimming does. 
However, it must be borne in mind that the actual development of EIA 
symptoms depends on various types of factors such as:  
a) difficulty and duration of physical exercise (e.g., free running > 
treadmill > cycloergometer);  
b) environmental factors (temperature and humidity, cold air, rapid re-
warming, pollutants such as SO2, NO2, particulate agents, tobacco smoke, or 
other, and aeroallergens); 
c) patient’s health and habits, namely the presence of respiratory 
infections (sinusitis, bronchitis) or the lack of pre-exercise warming up. 
  
Clinical aspects of EIA 
 
Exercise-induced asthma manifests itself just like any other form of asthma. 
In fact, it may involve shortness of breath and wheezing, although it may simply 
manifest as dry cough. As mentioned in terms of the pathophysiology, EIA-
related symptoms may start during exercise although, more often, they only 
become apparent a few minutes after having stopped the exercise. Curiously 
enough, as mentioned before, once the symptoms resolve, a refractory period 
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ensues, during which the patient may again engage in physical exercise without 
developing any symptoms.   
In general, there are some clinical features that may alert towards the 
presence of a situation of exercise-induced asthma in a student or athlete: 
 - Feeling of chest tightness; 
- Dry cough (after physical exercise or at night) 
- Prolonged shortness of breath (dyspnoea) 
- Difficulty falling asleep 
- Post-exercise wheezing 
- Well trained athlete demonstrating lower than expected performances 
- Family history of bronchial asthma 
- Personal history of allergies and allergic rhinitis 
 
Diagnosis of EIA 
 
There are various parameters that help to reach a diagnosis of exercise-
induced asthma. These include: 
a) Relevant clinical aspects (environmental triggers, types of 
symptoms, personal and/or family history, etc); 
b) Altered lung function tests (showing bronchial obstruction); 
c) Altered forced exercise test (spirometry; oximetry) 
a. Performed outdoors, in usual training conditions (field 
challenge); 
b. Performed indoors, at a specific laboratory environment 
(treadmill; eucapneic hyperventilation). 
 
Forced exercise testing may be crucial for the diagnosis of EIA in that it 
may be the only way to reproduce and quantify the symptoms. 
 
Approach to EIA  
 
Various measures may be taken with a view to improving the situation of 
exercise-induced asthma. These include aspects related to: 
a) Appropriate selection of physical exercise; 
b) Correct medical advice; 
c) The role of schools and sports clubs. 
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a) Appropriate selection of physical exercise 
 
The general idea will be to choose the type of physical exercise that is less 
“asthmogenic”, provided it is appealing to the person performing it. This will 
depend on the existence or not of previous allergic diseases in the patient as 
well as on environmental conditions. It should also be remembered that, in 
some cases, the same type of physical exercise may be practised either indoors 
or outdoors. In this context, whenever outdoor conditions are more critical for 
patients with EIA (e.g., strong wind, cold air, high pollen counts, high pollutant 
levels), it is possible for the exercise to carried out indoors. 
 
b) Correct medical advice 
 
It is very important to seek medical help whenever EIA is suspected. In 
this regard a specialist doctor (Allergist) will be able to assess the situation and 
give appropriate advice. This will involve recommendations regarding the best 
type of physical exercise but also preventive measures and therapeutic 
approaches (what to do when EIA occurs). 
 
c) The role of schools and sports clubs 
 
Schools and sports clubs are very important for dealing with children and 
adults with EIA. In this regard, the coach and physical education (PE) teacher 
have a crucial role. 
 
Coaches, PE teachers and EIA 
 
Both coaches and PE teachers must be aware of “cloakroom” cough in an 
athlete or PE student. It will be more apparent after a game or a session of 
physical exercise. In addition, well trained athletes with EIA may be detected 
because of an otherwise unexplained lack of mid-season form. Coaches should 
also be aware that athletes are trained to withstand pain and discomfort and 
may therefore be less prone to acknowledge the presence of any symptoms. In 
addition, athletes are also afraid of having to take medication and thereby be 
accused of doping. 
 
Both coaches and PE teachers should be prepared to take appropriate 
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action with EIA patients. This will imply appropriate training and information. 
These measures are as follows: 
a) To have an asthma emergency action plan (preferably discussed 
with an Allergist); 
b) To know how to measure lung function using a mini-Wright peak 
flow meter; 
c) To ensure that all asthmatic athletes or students involved in 
physical exercise bring their rescue inhalers to training sessions; 
d) To make sure that the school or club has a spare inhaler device 
and a spacer for using it (Figure …); 
e) To know how to use a spacer for the inhalers; 
f) To have alternative training places and plans for asthmatic athletes 
or students, in case they are necessary; 
g) To adapt pre-warming periods to asthmatic patients; 
h) To ensure that asthmatic patients are regularly seen by an Allergist; 
i) To know the basics of asthma therapy, particularly in terms of 
rescue medication (inhaled bronchodilators) 
 
 
 
Figure 2.  Metered-dose inhaler  ( in green) coupled to a large spacer  devi ce .  
 
 
Athletes and EIA 
 
It is important to note that, apart from coaches or PE teachers, the 
principal person that should actively be engaged in dealing with EIA is the 
asthmatic athlete himself. In this regard, people performing physical exercise, 
namely athletes, should thoroughly know what asthma and EIA are. In addition, 
the athlete should be knowledgeable about the different types of clinical 
manifestations of EIA and should also rigorously follow the rules of medication 
prescribed by the Allergist. It is useful for the professional athlete to be aware 
of medication that is allowed and not allowed for doping reasons. This can be 
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looked up at http://www.wada-ama.org/en/. It is also important to know 
how to take the medication and to be familiar with spacers for inhalers. Finally, 
it is crucial to know how to avoid exposure to pollutants and aeroallergens. 
 
Practical aspects for dealing with EIA 
 
a) Pre-medication 
Patients with EIA may significantly reduce or totally abrogate symptoms if 
they take their rescue medication preventively. This implies inhaling a short- 
(terbutaline or salbutamol) or long- (formoterol or salmeterol) acting β2-
agonist, 5 to 10 minutes before starting physical exercise. This approach will 
reduce underlying, unapparent bronchial constriction and prevent exercise-
induced bronchoconstriction. This type of medication is permitted in asthmatic 
athletes since they only act as anabolizers and stimulator drugs in high doses.   
 
b) Medical control of baseline asthma 
It is important to remember that bronchial asthma (and EIA) involve the 
presence of bronchial inflammation. In this context, prolonged use of anti-
inflammatory inhalers (corticosteroids such as fluticasone or budesonide) may 
very significantly reduce the probability of development of bronchial 
constriction, by inhibiting local inflammation which may be crucial in the 
pathophysiology of EIA. These drugs are only permitted in an inhaled form in 
asthmatic athletes. In addition, they may also be applied topically on the skin.  
 
c) Correct training session (and pre-warming) 
It is crucial for a correct pre-warming phase to be included in training 
sessions. Training sessions should be performed on a regular basis because this 
may contribute towards reducing the development of EIA in an athlete. 
Training sessions should be adapted to the asthmatic athlete / student and 
triggers should be avoided (cold air, etc). 
 
d) Medical and psychological support 
Medical support is crucial for the correct preventive and therapeutic 
approach to asthma and EIA. In addition, psychological support may also be 
crucial in terms of motivating for performing physical exercise in spite of EIA 
and also for dealing with this type of illness. 
 
e) Other measures 
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Other measures may be taken in order to reduce the probability of 
developing EIA, although some of them are not totally proven. These include 
reducing salt intake, poly-unsaturated fatty acid supplementation, and avoidance 
of aspirin. 
 
In Summary 
 
Exercise-induced asthma is a situation which is more frequent than 
generally thought. It is crucial that an asthmatic athlete or student does not give 
up physical exercise or hide his illness from his coach or PE teacher. Both 
coach / PE teacher and asthmatic athlete / student  should be aware of 
preventive and therapeutic measures for EIA. Training sessions should be 
adapted to EIA athletes / students. A number of these studies have reported 
some reductions in hospitalisations, wheeze frequency, school absenteeism, 
doctor consultations and medication usage in asthmatic children that perform 
physical exercise on a regular basis. It is, therefore, recommended that children 
and adolescents with asthma should participate in regular physical activity. 
Generally speaking, it is crucial that a stable, controlled situation is attained, so 
that people involved in physical exercise carry on enjoying their activities in 
spite of EIA and may achieve the same goals as those the people that do not 
have EIA. 
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Abstract 
 
Prolonged exercise and heavy training are associated with depressed 
immune cell function. To maintain immune function, athletes should eat a well 
balanced diet sufficient to meet their energy, carbohydrate, protein and 
micronutrient requirements. Consuming carbohydrate during prolonged 
strenuous exercise attenuates rises in stress hormones and appears to limit the 
degree of exercise-induced immune depression. Recent evidence suggests that 
antioxidant vitamin supplementation may also reduce exercise stress and 
impairment of leukocyte functions. Further research is needed to evaluate the 
effects of other antioxidants and dietary immunostimulants such as probiotics 
and echinacea on exercise-induced immune impairment. 
 
Immune function and the nutrition of elite athletes 
 
The immune system protects against, recognises, attacks and destroys 
elements that are foreign to the body. The immune system can be divided into 
two broad functions: innate (natural and non-specific) and acquired (adaptive 
and specific) immunity which work together synergistically. The attempt of an 
infectious agent to enter the body immediately activates the innate system. This 
so-called ‘first-line of defence’ comprises three general mechanisms with the 
common goal of restricting micro-organism entry into the body: (1) 
physical/structural barriers, (skin, epithelial linings, mucosal secretions); (2) 
chemical barriers, (pH of bodily fluids and soluble factors such as lysozymes 
and complement proteins); and (3) phagocytic cells (e.g. neutrophils and 
monocytes/macrophages) and cytotoxic cells (natural killer cells). Failure of the 
innate system and the resulting infection activates the acquired system, which 
aids recovery from infection. Monocytes or macrophages ingest, process and 
present foreign material (antigens) to lymphocytes. This is followed by clonal 
proliferation of T- and B-lymphocytes that possess receptors that recognise the 
antigen, engendering specificity and ‘memory’ that enable the immune system to 
mount an augmented cell-mediated and humoral (antibody) response when the 
 45 
host is reinfected by the same pathogen. 
Critical to the activation and regulation of immune function is the 
production of cytokines including interferons,interleukins and colony 
stimulating factors. A fundamental characteristic of the immune system is that it 
involves multiple functionally different cell types which permits a large variety 
of defence mechanisms. Assessing immune function status therefore requires a 
thorough methodological approach targeting a large spectrum of immune 
system parameters. However, currently no instruments are available to predict 
the cumulative effects of several small changes in immune cell functions 
determined in vitro on host resistance to infection (1). 
A heavy schedule of training and competition can lead to immune 
impairment in athletes and this is associated with an increased susceptibility to 
infections, particularly upper respiratory tract infections (URTI) (2,3). This 
exerciseinduced immune dysfunction seems to be mostly due to the 
immunosuppressive actions of stress hormones such as adrenaline and cortisol. 
Since many of the immunological changes to acute exercise appear to arise in 
response to stress hormones, factors such as exercise intensity, duration and 
subject fitness, which influence stress hormone secretion, will affect the 
immune response. Both circulating leukocyte numbers and functions are 
affected by catecholamines (4), which are elevated by acute exercise in an 
intensity dependent manner. Subject fitness has a bearing on the relative 
intensity of a bout and will, therefore, alter the immunological outcome to an 
acute exercise bout (5). Furthermore, exercise-induced elevations in cortisol 
affect the leukocyte count and function, and the secretion of this hormone is 
affected by the intensity and duration of exercise (6). Mild to moderate exercise 
(<50% VO2max) seems to reduce cortisol concentrations due to an enhanced 
elimination and a suppressed secretion, whereas more intense exercise (>60% 
VO2max) increases cortisol (6). However, if the bout is sufficiently prolonged, 
even relatively moderate intensities can elicit increases in cortisol because it is 
released to increase gluconeogenesis and maintain blood glucose concentrations 
(7). Exercise intensity and duration both contribute to the metabolic stress of 
the bout and thus influence fuel depletion. Since recent evidence suggests 
skeletal muscle can release IL-6 when fuel provision becomes challenged8 and 
this cytokine is known to have immunological actions (9) factors such as 
intensity, duration and subject fitness that can influence metabolic demand will 
affect the immunological outcome. 
Acute exercise appears to modify T cell function and as for many other 
aspects of immune function, such effects are proportional to exercise intensity 
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and duration. There is evidence that prolonged acute exercise is associated with 
a decrease in T cell IL-2 and IFN-  production immediately after exercise, and 
a decline in the number of circulating T cells that secrete IFN-  (10). There are 
numerous reports in the literature of decreased mitogen-stimulated T cell 
proliferation following acute exercise (11,12) but interpretation of these findings 
may be confounded by the presence of NK cells and B cells in the cell cultures. 
Furthermore, it should be remembered that in vitro stimulation with 2 mitogen 
does not necessarily reflect the more subtle responses of cells following a 
specific antigen encounter within the body. Moreover, exercise may alter T cell 
function in vitro through an increase in the rate of apoptosis in cell culture rather 
than a decrease in T cell proliferation (13). 
The effect of exercise on humoral immune function has been assessed 
through measurements of serum and mucosal Ig concentration in vivo and 
lymphocyte Ig synthesis following in vitro mitogen-stimulation. Serum Ig 
concentration appears to remain either unchanged, or slightly increased, in 
response to either brief or prolonged exercise (14). Mucosal Ig production has 
been chiefly assessed by measurement of IgA in saliva, with intensive exercise 
frequently associated with a decline in s-IgA concentration and/or secretion 
rate (15). 
In general post-exercise immune function depression is most pronounced 
when the exercise is continuous, prolonged (>1.5 hours), of moderate to high 
intensity (55-75% VO2max) and performed without food intake. Periods of 
intensified training (overreaching) lasting one week or more result in chronically 
depressed immune function (16). Although elite athletes are not clinically 
immune deficient, it is possible that the combined effects of small changes in 
several immune parameters may compromise resistance to common minor 
illnesses such as URTI. 
Protracted immune depression linked with prolonged training may 
determine susceptibility to infection, particularly at times of major competitions 
(15). Hundreds of studies have now been conducted that confirm both acute 
and chronic effects of exercise on the immune system, yet there are still very 
few studies that have been able to show a link between exercise-induced 
immune depression and increased incidence of illness in athletes. This is an 
important issue that needs to be addressed in future studies, though it must be 
recognised that this is a difficult task. Even among the general population we 
do not know the impact of small changes in specific immune parameters on risk 
of infection (1). Most clinical studies have only been concerned with the risk of 
life-threatening illness in immunodeficient patients, not with the risks of picking 
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up common infections such as colds and flu. 
Nutritional deficiencies can also impair immune function and there is a vast 
body of evidence that many infections are increased in prevalence or severity by 
specific nutritional deficiencies (17). However, it is also true that excessive 
intakes of individual micronutrients (e.g. n-3 polyunsaturated fatty acids, iron, 
zinc, vitamins A and E) can impair immune function and some (particularly 
excess iron) can increase the risk of infection (17). As most athletes will be 
aware, even medically harmless infections can result in a decrement in athletic 
performance. This review will consider the various components of the diet that 
can potentially influence the degree of exercise-induced immunodepression. 
Undoubtedly, a key to maintaining an effective immune system is to avoid 
deficiencies of the nutrients that play an essential role in immune cell triggering, 
interaction, differentiation or functional expression. Malnutrition decreases 
immune defences against invading pathogens and makes the individual more 
susceptible to infection (17,18). Infections with certain pathogens can also 
affect nutritional status by causing appetite suppression, malabsorption, 
increased nutrient requirements and increased losses of endogenous nutrients 
(18). 
 
Macronutrients  
 
Protein and energy 
It is well accepted that an inadequate intake of protein impairs host 
immunity with particularly detrimental effects on the T-cell system, resulting in 
increased incidence of opportunistic infections (17,18). It is not surprising that 
protein deficiency impairs immunity because immune defences are dependent 
on rapid cell replication and the production of proteins with important 
biological activities such as immunoglobulins, acute phase proteins and 
cytokines. In humans, protein-energy malnutrition (PEM) has been found to 
depress the number of mature, fully differentiated T lymphocytes and the in 
vitro proliferative response to mitogens, although the latter is reversible with 
nutritional repletion (19). Additionally, in PEM the T-lymphocyte 
CD4+/CD8+ (helper/suppressor cell) ratio is markedly decreased and 
phagocytic cell function, cytokine production, and complement formation are 
all impaired. 
Essentially all forms of immunity have been shown to be affected by PEM 
in humans, depending on the severity of the protein deficiency relative to 
energy intake. While it is unlikely that athletes would ever reach a state of such 
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extreme malnutrition unless dieting very severely, some impairment of host 
defence mechanisms is observed even in moderate protein deficiency (19). 
Among the athletic population, individuals at most risk from protein deficiency 
are those undertaking a programme of food restriction in order to lose weight, 
vegetarians and athletes consuming unbalanced diets (e.g. with an excessive 
amount of carbohydrate at the expense of protein). Often, deficiencies in 
protein and energy will be accompanied by deficiencies in micronutrients. 
Energy-restricted diets are common in sports where leanness or low body mass 
is thought to confer a performance or aesthetic advantage (e.g. gymnastics, 
figure skating, endurance running) or is required to meet certain body weight 
categories (e.g. boxing, martial arts, weight lifting, rowing). Indeed, this has lead 
to the identification of a new subclinical eating disorder 'anorexia athletica' 
which has been associated with an increased susceptibility to infection (20). 
Even short-term dieting can influence immune function in athletes. For 
example, it has been shown that a loss of 2 kg body mass over a 2-week period 
adversely affects macrophage phagocytic function (21). 
 
Fat 
Relatively little is known about the potential contribution of dietary fatty 
acids (FA) to the regulation of exercise induced modification of immune 
function. Two groups of polyunsaturated fatty acids (PUFA) are essential to the 
body: the omega-6 (n-6) series, derived from linoleic acid and the omega-3 (n-3) 
series, derived from linolenic acid. These FA cannot be synthesised in the body 
and therefore must be derived from the diet. There are reports that diets rich in 
n-3 PUFA improve the conditions of patients suffering from diseases 
characterised by an over-active immune system, such as rheumatoid arthritis; 
that is to say they have anti-inflammatory effects (18). It has been suggested 
that high intakes of n-6 PUFA such as arachidonic acid relative to intakes of FA 
of the n-3 group may exert an undesirable influence on inflammation and 
immune function during and after exercise (22), though direct evidence of this 
is currently lacking. However, a recent study showed that n-3 PUFA 
supplementation did not influence the exercise-induced elevation of pro- or 
anti-inflammatory cytokines (23). More research is needed on the effects of 
altering essential FA intake on immune function after exercise and during 
periods of heavy training. 
 
Carbohydrate 
Since many aspects of exercise-induced immune function impairment seem 
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to be caused by elevated levels of stress hormones, nutritional strategies that 
effectively reduce the stress hormone response to exercise would be expected to 
limit the degree of exercise-induced immune dysfunction (24). There is certainly 
some considerable experimental evidence that supports a beneficial effect of 
carbohydrate (CHO) feeding during exercise (25,26), although it is not clear if 
the magnitude of such effects is sufficient to affect infection risk. 
Consumption of CHO during exercise attenuates (i.e. reduces the 
magnitude of) rises in plasma catecholamines, growth hormone, 
adrenocorticotrophic hormone, cortisol (Figure 1) and cytokines (25). 
 
 
 
Figure 1. Consumption of 30-60 g carbohydrate per hour as a 6.4% w/v 
beverage during 2.5 h strenuous cycling exercise attenuates rises in plasma 
cortisol observed on the placebo trial. 
 * significantly different to pre-exercise, P<0.05; # significantly lower than 
PLA, P<0.05. Note that ingesting a small amount of carbohydrate as a 2% w/v 
beverage has no significant effect on the plasma cortisol response to exercise. 
The volume of drinks consumed was 500 ml immediately preexercise and 200 
ml every 20 min during exercise. Data from Lancaster et al.(15). 
  
 
CHO intake during exercise also attenuates the trafficking of most 
leukocyte and lymphocyte subsets, including the rise in the 
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neutrophil:lymphocyte ratio (25), prevents the exercise-induced fall in 
neutrophil function (27) and reduces the extent of the diminution of mitogen-
stimulated T-lymphocyte proliferation (28) following prolonged exercise (Figure 
2).  
 
 
 
Figure 2. Mode of action of carbohydrate and antioxidant supplements in 
limiting exercise-induced immune function depression. Carbohydrate ingestion 
during prolonged exercise maintains plasma glucose availability and limits rises 
in circulating IL-6, cortisol and adrenaline. Antioxidant supplementation for 
several weeks also attenuates rises in circulating IL-6 and cortisol during 
exercise, elevates the plasma antioxidant capacity and scavenges reactive oxygen 
species (ROS) generated by active muscle and activated neutrophils. 
 
 
Very recently, it was shown that consuming 30-60 g of CHO per hour 
during 2.5 h of strenuous cycling prevented both the decrease in the number 
and percentage of interferon (IFN)-  positive T lymphocytes and the 
suppression of IFN-  production from stimulated T lymphocytes (Figure 3) 
observed on the placebo control trial.10 IFN-  production is critical to 
antiviral defence and it has been suggested that the suppression of IFN-  
production may be an important mechanism leading to an increased risk of 
infection after prolonged exercise bouts (29).  
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Figure 3 Consumption of 30-60 g carbohydrate per hour as a 6.4% w/v 
beverage during 2.5 h strenuous cycling exercise prevents the suppression of 
interferon (IFN)-  production from stimulated T lymphocytes observed on the 
placebo control trial. * significantly lower than pre-exercise, P<0.05. Note that 
ingesting a small amount of carbohydrate as a 2% w/v beverage is not so 
effective. The volume of drinks consumed was 500 ml immediately pre-exercise 
and 200 ml every 20 min during exercise. Data from Lancaster et al. (15). 
 
 
In a randomised, counterbalanced, crossover study carbohydrate beverage 
compared with placebo beverage ingestion during a 3-h treadmill run at 
70%VO2max attenuated plasma levels of interleukin (IL)-6, and IL-10 and 
muscle gene expression for IL-6 and IL-8.30 The 3-h treadmill run in both the 
CHO and placebo trials induced gene expression within the muscle for two 
primary proinflammatory cytokines IL-1  and tumour necrosis factor- . IL-6 
and IL-8, which are often considered to be components of the secondary 
inflammatory cascade, were also expressed, but to a smaller degree in the CHO 
trial. Anti-inflammatory indicators, including plasma IL-1-receptor antagonist, 
IL-10, and cortisol, were also decreased with CHO feeding. These data suggest 
that CHO ingestion attenuates the secondary but not the primary pro-
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inflammatory cascade, decreasing the need for immune responses related to 
anti-inflammation (30). 
When CHO is ingested during prolonged exercise, the release of IL-6 from 
working muscles can be totally inhibited (31) and the exercise-induced 
expression of a number of metabolic genes are blunted compared with exercise 
in the fasted state (32). Infusion of IL-6 in humans stimulates cortisol secretion 
(with plasma cortisol levels reaching similar values to those observed during 
exercise and with a similar timecourse) and induces lipolysis as well as eliciting a 
strong anti-inflammatory response (33). Thus, although CHO ingestion during 
exercise attenuates the IL-6 response and so reduces the magnitude of the 
cortisol-induced lymphocytopenia, it will, at the same time, inhibit lipolysis, 
reduce the anti-inflammatory cytokine response to exercise and attenuate the 
expression of a number of metabolic genes in the exercised muscle. In other 
words, it is possible that CHO ingestion during exercise sessions could limit 
metabolic adaptation of skeletal muscle to training. However, it can also be 
argued that CHO intake during training allows the athlete to work harder and 
longer and as yet there is no evidence that physiological and performance 
adaptations are impaired by CHO intake during training sessions. Indeed, recent 
studies indicate that appropriate CHO intake is necessary for improvements in 
endurance performance following periods of intensified training that 
temporarily induce overreaching (34, 35). 
 
While CHO feeding during exercise appears to be effective in minimising 
some of the immune perturbations associated with prolonged continuous 
strenuous exercise, it seems less effective for less demanding exercise of an 
intermittent nature, for example football (36) or rowing (37) training. It is also 
apparent that CHO feeding is not as effective in reducing immune cell 
trafficking and functional depression when continuous prolonged exercise is 
performed to the point of fatigue (38). Pre-exercise feeding of CHO does not 
seem to be very effective in limiting exercise-induced leukocytosis or depression 
of neutrophil function.39 It must also be said that evidence that the beneficial 
effect of feeding CHO on immune responses to exercise actually translates into 
a reduced incidence of URTI following prolonged exercise such as marathon 
races is currently lacking. Although a trend for a beneficial effect of CHO 
ingestion on post-race URTI was reported in a study of 98 marathon runners, 
40 this did not achieve statistical significance and larger scale studies are needed 
to investigate this possibility. 
The size of the glycogen stores in muscle and liver at the onset of exercise 
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will also influence the hormonal and immune response to exercise. The amount 
of glycogen stored in the body is rather limited (usually less than 500 g) and is 
affected by recent physical activity and the amount of dietary carbohydrate 
intake. When individuals perform prolonged exercise following several days on 
very low CHO diets (typically <10% of dietary energy intake from CHO), the 
magnitude of the stress hormone (e.g. adrenaline and cortisol) and cytokine (e.g. 
IL-6, IL-1ra and IL-10) response is markedly higher than on normal or high 
CHO diets.41,42 It has been speculated that athletes deficient in CHO are 
placing themselves at risk from the known immunosuppressive effects of 
cortisol, including the suppression of antibody production, lymphocyte 
proliferation and NK cell cytotoxic activity. In the study by Mitchell et al.(42) it 
was observed that exercising (1 h at 75% VO2max) in a glycogen depleted state 
(induced by prior exercise and 2 days on a low CHO diet) resulted in a greater 
fall in circulating lymphocyte numbers at 2 h postexercise compared with the 
same exercise performed after 2 days on a high CHO diet. In this study the 
manipulation of CHO status did not affect the decrease in mitogen-stimulated 
lymphocyte proliferation that occurred after exercise. However, a more recent 
study by Bishop et al.(43) showed that lymphocyte proliferation responses to 
mitogen and influenza were lower 24 h following a 90-minute intermittent high 
intensity exercise bout when subjects consumed a placebo beverage compared 
with a carbohydrate beverage before, during and following the exercise bout 
(Figure 4). Interestingly, these differences were independent of changes in the 
plasma cortisol 
concentration, implying that these CHO effects were mediated via a 
different mechanism. 
 
Fluid intake during exercise 
 
The consumption of beverages during exercise not only helps prevent 
dehydration (which is associated with an increased stress hormone response) 
but also helps to maintain saliva flow rate during exercise. Saliva contains 
several proteins with antimicrobial properties including IgA, lysozyme and  -
amylase. Saliva secretion usually falls during exercise. Regular fluid intake during 
exercise is reported to prevent this effect and a recent study has confirmed that 
regular consumption of lemon-flavoured CHO-containing drinks helps to 
maintain saliva flow rate and hence saliva IgA secretion rate during prolonged 
exercise compared with a restricted fluid intake regimen (44). 
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Figure 4. Mitogen (phytohemagglutinin)-stimulated T lymphocyte 
proliferative response (fold increase relative to unstimulated cells) before and 
after two bouts of high intensity intermittent exercise performed on consecutive 
days with either carbohydrate (6.4% w/v) or placebo beverage ingestion before, 
during and after exercise bout. * significantly higher than PLA, P<0.05. # 
significantly lower than pre-exercise on Day 1 (PLA only), P<0.05. Data from 
Bishop et al.(30). 
 
 
Micronutrients 
 
Minerals 
 
Several minerals are known to exert modulatory effects on immune 
function, including zinc, iron, magnesium, manganese, selenium and copper, yet 
with the exception of zinc and iron, isolated deficiencies are rare. Field studies 
consistently associate iron deficiency with increased morbidity from infectious 
disease.17,18 Furthermore, exercise has a pronounced effect on both zinc and 
iron metabolism.45 Requirements for these minerals are certainly higher in 
athletes compared with sedentary people because of increased losses in sweat 
and urine. However, excess intakes of some minerals (particularly iron and zinc) 
can impair immune function and, at least for iron, have been shown to increase 
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susceptibility to infection.17,18,45 Hence, supplements should be taken only as 
required and regular monitoring of iron status (serum ferritin and blood 
haemoglobin) and zinc status (erythrocyte or leukocyte zinc content) is 
probably a good idea. 
The efficacy of zinc supplementation as a treatment for the common cold 
has been investigated in at least 11 studies that have been published since 1984. 
The findings have been equivocal and recent reviews of this topic have 
concluded that further research is necessary before the use of zinc supplements 
to treat the common cold can be recommended (46,47). Although there is only 
limited evidence that taking zinc supplements reduces the incidence of 
URTI (48) in the studies that have reported a beneficial effect of zinc in 
treating the common cold (i.e. reduction of symptom duration and/or severity) 
it has been emphasised that zinc must be taken within 24 h of the onset of 
symptoms to be of any benefit. Potential problems with zinc supplements 
include nausea, bad taste reactions, lowering of HDL-cholesterol, depression of 
some immune cell functions (e.g. neutrophil oxidative burst) and interference 
with the absorption of copper (45).  
 
Vitamins 
Several vitamins are essential for normal immune function. Deficiencies of 
fat-soluble vitamins A and E and watersoluble vitamins folic acid, B6, B12 and 
C impair immune function and decrease the body’s resistance to infection 
(17,18). Correcting existing deficiencies with specific vitamin supplements can 
be effective in restoring immune function to normal levels and moderately 
increasing the intake of some vitamins (notably vitamins A andE) above the 
levels normally recommended may enhance immune function, particularly in 
the very young and the elderly (17). Consuming megadoses of individual 
vitamins, which appears to be a common practice in athletes, can actually impair 
immune function and have other toxic effects (18). In a recent exercise study, 
supplementation of athletes with 600 mg.day-1 vitamin E for two months prior 
to an Ironman triathlon event resulted in elevated oxidative stress and 
inflammatory cytokine responses during the triathlon compared with placebo 
(49). In a study on elderly people (n=652) a daily 200 mg vitamin E supplement 
increased the severity of infections, including total illness duration, duration of 
fever and restriction of physical activity (59). However, in that study, health 
assessment was by self-evaluation which could be a limiting factor, particularly 
in an elderly population whose cognitive function was not described. In a recent 
large placebocontrolled trial (n=617 elderly nursing home residents) by Meydani 
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et al. (51) which used weekly documentation by nurses and physicians to assess 
health status, fewer participants receiving daily supplementation with 200 IU 
vitamin E aquired one or more respiratory tract infections and the vitamin E 
group had a lower incidence of colds than the placebo group. Recently, vitamin 
E supplementation (600 mg.day-1) in patients with ischaemic heart disease has 
been demonstrated to have either no effect on all cause mortality (52) or to 
increase the number of cases who died compared with placebo (53). In contrast 
in a large cohort of women (n=22,000) , there was a 24% reduction in risk for 
cardiovascular death for those who took a supplement of 600 IU/day vitamin E 
every other day for 10 years and no effect on overall mortality (54). Meydani et 
al.(55) concluded that 200 mg of vitamin E daily represents the optimal level for 
the immune response. Intakes in excess of 300 mg/day of vitamin E in the 
human diet have been associated with decreases in phagocytic cell functions 
(56,57). Megadoses of vitamin A may impair the inflammatory response and 
complement formation as well as having other pathological effects, including 
causing an increased risk of foetal abnormalities when consumed by pregnant 
women (5). 
Vitamins with antioxidant properties including vitamins A, C, E and  -
carotene (provitamin A) may be required in increased quantities in athletes in 
order to inactivate the products of exercise-induced reactive oxygen species 
(ROS) generation (58). However, there are no convincing data demonstrating 
an effect of nutritional antioxidants on exercise performance. Increased oxygen 
free-radical formation that accompanies the dramatic rise in oxidative 
metabolism during exercise could potentially inhibit immune responses (18,59) 
and contribute to exercise-induced lymphocytopenia by activating apoptosis (an 
internal program that allows cells to commit suicide) (60) ROS inhibit 
locomotory and bactericidal activity of neutrophils, inhibit natural killer (NK) 
cell cytotoxic activity, reduce the proliferation of T- and B-lymphocytes and 
promote lymphocyte apoptosis (Figure 2) (60). Sustained endurance training 
appears to be associated with an adaptive up-regulation of the antioxidant 
defence system (61) though this may be insufficient to protect athletes who 
train extensively (58) Vitamin C (ascorbic acid) is found in high concentration 
in leukocytes and has been implicated in a variety of antiinfective functions 
including promotion of T-lymphocyte proliferation, prevention of 
corticosteroid-induced suppression of neutrophil activity, and inhibition of 
virus replication.62 It is also a major water-soluble antioxidant that is effective 
as a scavenger of ROS in both intracellular and extracellular fluids. Vitamin C is 
also required for the regeneration of the reduced form of the lipid-soluble 
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antioxidant, vitamin E. 
In a study by Peters et al. (63) using a double blind placebo research design, 
it was determined that daily supplementation of 600 mg (15 times the RNI) of 
vitamin C for 3 weeks prior to a 90-km ultramarathon reduced the incidence of 
symptoms of URTI (68% compared with 33% in age- and sex-matched control 
runners) in the 2 week post-race period. In a follow-up study, Peters et al.64 
randomly divided participants in a 90-km ultramarathon (n=178), and their 
matched controls (n=162) into four treatment groups receiving either 500 mg 
vitamin C alone, 500 mg vitamin C plus 400 IU vitamin E (1IU is equivalent to 
0.67 mg), 300 mg vitamin C plus 300 IU vitamin E plus 18 mg  -carotene, or 
placebo. As runners were requested to continue with their usual habits in terms 
of dietary intake and the use of nutritional supplements, total vitamin C intake 
of the 4 groups was 1004, 893, 665, and 585 mg daily, respectively. The study 
confirmed previous findings of a lower incidence of symptoms of URTI in 
those runners with the highest mean daily intake of vitamin C and also indicated 
that the combination of water-soluble and fat-soluble antioxidants was not 
more successful in attenuating the post-exercise infection risk than vitamin C 
alone (Figure 5). This 
study certainly provides some support for the notion that megadoses of 
vitamin C reduce URTI risk in endurance athletes, though a limitation is that 
infection symptoms were self-reported and not clinically confirmed in these 
studies. However, some similar studies have not been able to replicate these 
findings: for example, Himmelstein et al.(65) reported no difference in URTI 
incidence among 44 marathon runners and 48 sedentary subjects randomly 
assigned to a 2-month regimen of 1000 mg.day-1 vitamin C or placebo. 
Furthermore, a subsequent double-blind, placebo controlled study found no 
effect of vitamin C supplementation (1000 mg.day-1 for 8 days) on the immune 
response to 2.5 h running (66), though a larger dose of vitamin C 
supplementation (1500 mg.day-1 for 7 days prior to the race and on race day) 
did reduce the cortisol and cytokine response to a 90-km ultramarathon race.67 
However, in the latter study, no difference in URTI incidence was found 
between subjects on vitamin C and placebo treatments. Again, URTI was self-
evaluated and a confounding factor in this study was that subjects consumed 
carbohydrate during the race ad libitum and this was retrospectively estimated. 
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Figure 5. The incidence of upper respiratory tract infection (URTI) in the 
week following the 1993 Comrades Marathon (90 km) in South Africa. 
Different groups of runners received different combinations of antioxidant 
supplements or placebo for 3 weeks prior to the ultramarathon. The incidence 
of URTI in a control group of 45 non-runners receiving placebo was 20%. Data 
from Peters et al.(46). 
 
 
 
In a more recent randomised, double blinded, placebo-controlled study, 
1500 mg.day-1 vitamin C for 7 days before an ultramarathon race with 
consumption of vitamin C in a carbohydrate beverage during the race (subjects 
in the placebo group consumed the same carbohydrate beverage without added 
vitamin C) did not affect oxidative stress, cytokine or immune function 
measures during and after the race (68). In contrast, it has recently been 
reported that 4 weeks combined supplementation with vitamin C (500 mg.day-
1) and vitamin E (400 IU.day-1) prior to a 3-h knee extension exercise protocol 
reduced muscle IL-6 release and reduced the systemic rise in both circulating 
IL-6 and cortisol (Figure 6) (69). Furthermore, administration of the antioxidant 
N-acetyl-L-cysteine (a precursor of glutathione) to mice prevented the exercise-
induced reduction in intracellular glutathione concentration and markedly 
reduced post-exercise apoptosis in intestinal lymphocytes.60 Thus, although 
there are some inconsistencies in the literature regarding antioxidant 
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supplementation and immune responses to exercise, there is some basis for 
believing that such supplementation could have beneficial effects in alleviating 
exercise-induced immunodepression. 
 
Dietary immunostimulants 
 
Glutamine 
 
Glutamine is the most abundant free amino acid in human muscle and 
plasma and is utilised at very high rates by leukocytes to provide energy and 
optimal conditions for nucleotide biosynthesis. Indeed, glutamine availability is 
considered important to lymphocytes and other rapidly dividing cells including 
the gut mucosa and bone marrow stem cells. Prolonged exercise is associated 
with a fall in the plasma concentration of glutamine and it has been 
hypothesised that such a decrease could impair immune function (70,71). It has 
been suggested that exogenous provision of glutamine supplements may be 
beneficial by maintaining the plasma glutamine concentration and hence 
preventing the impairment of immune function following prolonged exercise. 
 
 
Figure 6. The effect of 4 weeks of antioxidant supplementation (500 
mg.day-1 vitamin C and 400 IU.day-1 vitamin E) compared with placebo on 
plasma cortisol responses to 3 h of dynamic knee extensor exercise. Data from 
Fischer et al.(51). 
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Castell et al. (72) have provided the only prophylactic evidence that an oral 
glutamine supplement (5 g in 330ml water) consumed immediately after and 2 h 
after a marathon reduces the incidence of URTI (in the 7 days following the 
race). However, it is unlikely that this amount of glutamine supplementation 
could actually have prevented the post-exercise fall in the plasma glutamine 
concentration. Provision of glutamine has been shown tohave a beneficial effect 
on gut function, morbidity and mortality and on some aspects of immune cell 
function in clinical studies of diseased or traumatised patients. However, several 
recent studies that have investigated the effect of large amounts of glutamine 
supplementation during and after exercise on the exercise-induced fall in 
lymphokine-activated killer cell activity, neutrophil function and mitogen-
stimulated lymphocyte proliferation have failed to find any beneficial effect 
(73,74). 
 
Branched chain amino acids 
 
Very recently, Bassit et al.75 reported that supplementation of branched 
chain amino acids (6 g.day-1 for 15 days) prior to a triathlon or 30-km run in 
experienced male triathletes and marathoners, respectively, prevented the ~40% 
decline in mitogen-stimulated lymphocyte proliferation observed in the placebo 
control group after exercise. Branched chain amino ingestion was associated 
with increased lymphocyte IL-2 and IFN-  production. The postexercise fall in 
plasma glutamine concentration was prevented by the branched chain amino 
acid ingestion, but it is not clear if this was the mechanism of action or if there 
was a direct effect of the branched amino acids themselves. 
More research is needed to resolve these conflicting findings of branched 
chain amino acids and glutamine supplementation on immune responses to 
exercise. 
 
 
 -carotene 
 
 -carotene (pro-vitamin A) acts both as an antioxidant and an 
immunostimulant, increasing the number of T-helper cells in healthy humans 
and stimulating NK cell activity when added in vitro to human lymphatic 
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cultures (76,77). Furthermore, elderly men who had been taking  -carotene 
supplements (50 mg on alternate days) for 10-12 years were reported to have 
significantly higher NK cell activity than elderly men on placebo (78). However, 
supplementing runners with  -carotene or vitamin A was found to have an 
insignificant effect on the incidence of URTI following a 90-km ultramarathon 
(64,79). 
 
 
Echinacea purpurea 
 
Several herbal preparations are reputed to have immunostimulatory effects 
and consumption of products containing Echinacea purpurea is widespread 
among athletes. However, few controlled studies have examined the effects of 
dietary immunostimulants on exercise-induced changes in immune function. In 
one recent double-blinded and placebo-controlled study, the effect of a daily 
oral pretreatment for 28 days with pressed juice of Echinacea purpurea was 
investigated in 42 triathletes before and after a sprint triathlon (80). Another 
subgroup of athletes was treated with a magnesium supplement. The most 
important finding was that during the 28-day pretreatment period, none of the 
athletes in the Echinacea group fell ill, compared with 3 subjects in the 
magnesium group and 4 subjects in the placebo group who became ill. 
Numerous experiments have demonstrated that Echinacea purpurea extracts 
do indeed demonstrate significant immunomodulatory activities. Among the 
many pharmacological properties reported, macrophage activation has been 
demonstrated most convincingly (81, 82). Phagocytotic indices and 
macrophage-derived cytokine concentrations have been shown to be 
Echinacea-responsive in a variety of assays and activation of 
polymorphonuclear leukocytes and NK cells has also been demonstrated.83 
Changes in the numbers and activities of T- and B lymphocytes have been 
reported, but are less certain. Despite this cellular evidence of 
immunostimulation, pathways leading to enhanced resistance to infectious 
disease have not been described adequately. Several dozen human experiments, 
including a number of blind randomized trials, have reported health benefits. 
The most robust data come from trials testing Echinacea purpurea extracts in the 
treatment for acute URTI. Although suggestive of modest benefit, these trials 
are limited both in size and in methodological quality. In a recent randomised, 
double-blind placebo-controlled trial, administering unrefined Echinacea at the 
onset of symptoms of URTI in 148 college students did not provide any 
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detectable benefit or harm compared with placebo (84). Hence, while there is a 
great deal of moderately goodquality scientific data regarding the in vitro effects 
of Echinacea on selected immune cell functions, its effectiveness in treating 
illness or in enhancing human health is still debated and it is not yet known if 
Echinacea is effective in modifying exercise-induced immunodepression. 
 
 
Probiotics 
 
Probiotics are food supplements that contain “friendly” gut bacteria. There 
is now a reasonable body of evidence that regular consumption of probiotics 
can modify the population of the gut microflora and influence immune function 
(85,86). Some studies have shown that probiotic intake can improve 
ratesofrecovery from rotavirus diarrhoea, increase resistance to enteric 
pathogens and promote anti-tumour activity; there is even some evidence that 
probiotics may be effective in alleviating some allergic and respiratory disorders 
in young children (see Kopp-Hoolihan (87) for a review). However, to date, 
there are no published studies of the effectiveness of probiotic use in athletes. 
 
 
Alcohol and caffeine 
 
Although there are some established health benefits of regular light-to-
moderate alcohol consumption including reduced risk of myocardial infarction, 
ischaemic stroke, diabetes and osteoporosis,88 it is well established that 
excessive intake of alcohol has negative effects on immune function.89 For 
other obvious reasons alcohol should not form a significant part of an athlete’s 
diet. Although red wine is contains flavonoids which are polyphenol 
compounds with potent antioxidant properties, these can be obtained, if 
desired, from the juice of black grapes. Polyphenols are also found in 
abundance in berries, green tea, dark chocolate and other foods. Caffeine is the 
most commonly consumed drug in the world, and athletes frequently use it as 
an ergogenic aid (90). It improves performance and endurance during 
prolonged exhaustive exercise.90,91 At present, there is little information of the 
effects of caffeine ingestion on immune function at rest or during exercise. 
Addition of pharmacological doses of caffeine to cell culture media is associated 
with a dose-dependent suppression of in vitro mitogen-stimulated lymphocyte 
proliferative responses and cytokine production in humans (92). In rats the in 
vivo administration of 6 mg kg-1 day-1 of caffeine caused NK cell cytotoxicity 
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and pokeweed mitogen-stimulated B cell proliferative response to be 
significantly decreased,93 though in the same study administration of three 
times this dose of caffeine was associated with a significant increase in 
phytohemagglutinin-stimulated T cell proliferation. In vitro, a broad range of 
caffeine concentration (1-1000 mg/l) exhibited dose-dependent inhibition of 
both B and T cell proliferative responses (93). Recent exercise studies have 
demonstrated that caffeine compared with placebo ingestion 1 h before a bout 
of intensive endurance exercise was associated with greater perturbations in 
numbers of circulating lymphocytes, CD4+ and CD8+ cells and an increased 
percentage of CD4+ and CD8+ cells expressing the early activation marker 
CD69 in vivo both before and after exercise (94). Furthermore, the post-exercise 
fall in neutrophil oxidative burst activity was attenuated by caffeine ingestion.95 
It is thought that these effects may be largely mediated through the caffeine’s 
action as an adenosine receptor antagonist and the inhibition of cyclic 
AMPspecific phosphodiesterase activity (92,94). 
 
 
Conclusions 
 
Dietary deficiencies of energy, protein and specific micronutrients are 
associated with depressed immune function and increased susceptibility to 
infection. An adequate intake of iron, zinc, and vitamins A, E, B6 and B12 is 
particularly important for the maintenance of immune function. Athletes need 
to avoid micronutrient deficiencies. 
To maintain immune function, athletes should eat a well balanced diet 
sufficient to meet their energy requirements. This should ensure an adequate 
intake of protein and micronutrients. For athletes on energy-restricted diets, 
vitamin supplements are desirable. 
An athlete exercising in a carbohydrate-depleted state experiences larger 
increases in circulating stress hormones and a greater perturbation of several 
immune function indices. Thus, sufficient carbohydrate intake to restore 
glycogen stores on a daily basis is desirable. Consumption of carbohydrate (30-
60 g.h-1) in drinks during prolonged exercise is recommended as this practice 
appears to attenuate some of the immunodepressive effects of prolonged 
exercise. However, the clinical significance of this is yet to be determined. 
Routine consumption of megadoses of vitamins and minerals is not 
advised. Excess intakes of some micronutrients (e.g. iron, zinc, vitamin A) can 
impair immune function. Convincing evidence that so-called “immune-
boosting” supplements including glutamine, echinacea, and probiotics prevent 
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exercise-induced immune impairment is currently lacking. Current evidence 
regarding the efficacy of such supplements in preventing or treating common 
infections is limited (particularly in athletes) and there is insufficient evidence to 
recommend these supplements at this time. It is still debatable as to whether 
antioxidant supplements are required or are desirable for athletes. There is 
conflicting evidence of the effects of high dose vitamin C in reducing post-
exercise incidence of URTI and this practice has not yet been shown to prevent 
exercise-induced immune impairment. Elevations of vitamin E intake up to 
about 200 mg/day seem to be effective in reducing URTI incidence in the 
general population and several recent studies indicate that several weeks of 
antioxidant vitamin (C and E) supplementation can attenuate stress hormone 
and cytokine responses to prolonged exercise. 
In summary, it appears that appropriate nutrition can go some way to 
limiting exercise-induced immunodepression and this remains a fertile area of 
future research. 
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Introduction 
 
Ascent to high altitude is a known stressor with physiologic and metabolic 
consequences. These adjustments to high altitude are further complicated by 
the added stress of physical activity. Such disruptions in homeostasis elicit 
sympathoadrenal responses designed to help an individual adapt to the stress 
imposed by high-altitude exposure. Specifically, over the past two decades, our 
group has examined the sympathoadrenal responses to both acute and chronic 
high-altitude exposure at the summit of Pikes Peak, CO (4,300 m) in sea level 
residents. Utilizing a variety of techniques and measurements (arterial blood 
sampling, 24-hr urinary excretion rates, and net uptake/release of 
catecholamines from the leg), we have documented the sympathoadrenal 
responses over time while at high altitude both at rest and during submaximal 
exercise. Via interaction with their specific adrenergic receptors (Table 1), the 
catecholamines play an important regulatory role in adjusting to a variety of 
stressors.   We have examined the physiologic and metabolic implications of 
these responses during altitude exposure under a variety of conditions (rest, 
exercise), subjects (men, women) and treatments (α- or β-adrenergic blockade). 
Finally, the potential mechanisms responsible for the dissociation of the adrenal 
medullary response from that of the sympathetic nervous system will be 
addressed in this review. Taken together, the results clearly indicate that the 
sympathoadrenal pathways play an essential role in the adaptations necessary to 
adjust to the stress imposed during high-altitude exposure. 
 
 
Acute High-Altitude Exposure 
 
Rest:  Upon acute exposure to 4,300 m, homeostasis is immediately 
disrupted due to the reduction in PIO2 resulting in PaO2 levels well below 
normal (SaO2 ~ 80% and PaO2 ~ 40 torr).  In an attempt to preserve O2 
delivery to essential tissues, a number of physiological adjustments are made 
initially in response to the stress of acute hypoxia. The sympathoadrenal 
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pathways play a critical role in adjusting to this perturbation in homeostasis.  
Specifically, we have demonstrated that upon acute exposure (within 4 hrs of 
arrival) arterial concentrations of epinephrine are significantly elevated at rest 
when compared to sea level values (­80-100%). Hypoxia has been shown to 
directly stimulate adrenal medullary epinephrine release resulting in increased 
arterial concentrations. The extent of this response is dependent upon the 
degree and severity of hypoxia with the decline in arterial oxygen content acting 
as the primary stimulus. This immediate adrenal medullary response is further 
supported when examining the 24-hr urinary excretion rates for epinephrine.  
This marker of daily adrenal activity indicates that urinary epinephrine excretion 
increases dramatically upon acute exposure to high altitude reaching a peak on 
days 2-4, then returns to sea level values after the first week of acclimatization . 
Arterial oxygen saturation falls to a nadir on arrival at high altitude and 
improves with subsequent ventilatory acclimatization (SaO2 ~ 88% and PaO2 ~ 
50 torr after 1 week). As the degree of hypoxia lessens during acclimatization 
epinephrine levels fall. An inverse relationship between SaO2 and arterial 
epinephrine concentration becomes apparent (r= 0.73, 21 days at 4,300 m). 
The epinephrine response to acute high-altitude exposure is primarily 
mediated via the β-adrenergic receptors and contributes immediately to 
improve oxygen delivery. Resulting are increases in heart rate, stroke volume 
(thus, increasing cardiac output), tissue vasodilation and bronchodilation) all 
promoting increased O2 delivery to tissues. Further, epinephrine is well known 
to activate both muscle and liver glycogenolysis thereby enhancing carbohydrate 
utilization as well as lactate production. A greater utilization of carbohydrates is 
a more economical use of O2 as more energy is derived per liter of O2 
consumed from carbohydrates (5.05 kcal/l) vs. that from fat (4.68 kcal/l). Thus, 
optimizing the energy yield per unit of O2 would be beneficial during times of 
limited O2 availability such as hypoxia. Additionally, the increase in β-adrenergic 
stimulation contributes to the elevation in metabolic rate associated with acute 
high-altitude exposure. 
The norepinephrine response to hypoxia is somewhat different than that 
observed for epinephrine. Most studies indicate that when compared to sea 
level values, resting plasma norepinephrine levels do not change significantly 
with acute hypoxia. However, while resting plasma norepinephrine remain 
unchanged, muscle sympathetic nerve activity has been shown to increase while 
breathing 8-12% O2 as well as during acute hypobaric hypoxia simulating 4,000-
6000 m.  In support of this, we have been able to demonstrate that within 4 
hours after arrival to 4,300 m, there was a significant increase in norepinephrine 
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release from the resting legs compared to values measured at sea level. This 
occurred despite the fact that plasma norepinephrine levels remained 
unchanged. Thus, increases in SNS activity likely occurs to a variety of vascular 
beds during acute hypoxia, however, such activity cannot generally be detected 
by measurement of plasma norepinephrine content alone. 
 Plasma levels of norepinephrine are a function of the rate of spillover 
into the circulation (approximately 10-20% of the norepinephrine released by 
sympathetic nerves under resting conditions), a small amount secreted by the 
adrenal medulla and, the rate of its removal or clearance from the plasma pool. 
There appears to be no direct effects of hypoxia on enhancing the prejunctional 
release of neuronal norepinephrine nor on intraneuronal metabolism and 
uptake of the neurotransmitter in muscle suggesting that the enhanced spillover 
observed in our studies is directly related to an increase in sympathetic activity.  
No change or an increase in clearance of plasma norepinephrine has been 
reported during acute hypoxia. An increase in clearance would actually tend to 
lower plasma levels and therefore would not explain the increases associated 
with altitude. However, no studies exist which have examined the effect of 
chronic high-altitude exposure on plasma clearance of norepinephrine. 
  
Exercise:  The sympathoadrenal response to exercise generally follows the 
pattern described above for resting conditions. The added stress of exercise (in 
addition to hypoxia) results in accentuated catecholamine levels for a given 
submaximal workload. The magnitude of the epinephrine response is 
dependent upon both the exercise intensity as well as the degree of hypoxia. We 
have shown that exercise at altitude at the same absolute workload (100 watts), 
representing 50 and 65% VO2max at sea level and 4,300 m, respectively, elicits 
significant increases in arterial epinephrine levels. Epinephrine values increase 
linearly over time during the 45-minute submaximal exercise with acute high 
altitude exposure while values for both sea level and chronic altitude exposure 
remained stable throughout the submaximal work bout. When the absolute 
workload is adjusted such that subjects are exercising at similar relative 
workloads (same % VO2max) during both normoxic and hypoxic conditions, 
increased plasma epinephrine levels are still found to persist during acute 
hypoxia. Thus, it appears that an additive effect exists such that the stress 
imposed by hypoxia (directly effecting adrenal activity) and exercise (primarily 
an SNS stimulation of adrenal activity) yield greater epinephrine levels than that 
found for just each stressor alone. 
 During exercise, acute hypoxia results in elevated levels of plasma 
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norepinephrine compared to sea level. When individuals exercise at the same 
absolute workloads achieving steady-state VO2, we have shown that 
norepinephrine levels are significantly elevated with acute hypoxia compared 
sea level.  However, it appears that the norepinephrine response during acute 
hypoxia is primarily dependent upon the relative work intensity. Thus, if 
subjects work at a similar percentage of VO2max under both conditions, the 
norepinephrine response is not significantly different between sea level and 
acute hypoxia.  
 
 
Acclimatization to High-Altitude 
 
Rest:  During acclimatization, arterial epinephrine levels decline toward sea 
level values. As noted above, resting epinephrine concentrations fall as arterial 
oxygenation increases suggesting that concentrations are likely related to 
increases in oxygen carrying capacity and reduction in the severity of 
hypoxemia. This decline in circulating epinephrine levels, in conjunction with 
the documented down-regulation of β-receptors in the heart, contributes to the 
reduction in resting heart rate observed over time at altitude. The combination 
of a waning β-stimulation and decreased receptor sensitivity likely play a role in 
the decline in resting cardiac output over time at altitude to sea level values.  
The norepinephrine response, however, as measured by both arterial and 
urinary levels, reacts in a very different manner than that observed for 
epinephrine. While plasma norepinephrine levels during acute exposure are 
similar to those found for sea level, concentrations rise significantly with time 
during the acclimatization period (70-100%). Furthermore, urinary 
norepinephrine gradually increases reaching a plateau on days 6-7 and staying 
elevated throughout the remaining 21 days at 4,300 m. This increase in SNS 
activity with chronic altitude exposure is further supported by measurements of 
net norepinephrine release across resting muscle. A dramatic reversal from net 
norepinephrine uptake by resting leg at sea level to that of net release after 
chronic exposure clearly reflects enhanced sympathetic nerve activity. This 
indicates that spillover from sympathetic nerves directed to skeletal muscle is a 
major contributor to the elevation observed in resting plasma norepinephrine 
with prolonged exposure to hypoxia. The Pikes Peak studies are the first to 
examine the effect of chronic hypoxia on skeletal muscle SNS activity, and to 
demonstrate a dissociation of sympathetic nerve activity (increasing) and 
adrenal medullary responses (decreasing) over time at high altitude.  
 79 
The mechanisms responsible for the increase in sympathetic activity that 
occur over time at altitude, however, remain to be determined. A direct effect 
of hypoxia on sympathetic nerve activity is not likely because sympathetic 
activity continues to increase with time at altitude while the degree of 
hypoxemia is decreasing. We have found a high correlation between the decline 
in plasma volume with the rise in norepinephrine over time at altitude (r = -
0.89). A reduction in blood or plasma volume is known to activate the 
sympathetics (via baroreceptor activity) in an attempt to maintain arterial 
pressure. However, a baroreceptor-mediated increase in sympathetic activity is 
unlikely as blood pressure is significantly elevated during acclimatization. The 
declining plasma volume with rising norepinephrine levels is probably a result, 
rather than a cause, of the increase in sympathetic activity.  End-tidal CO2 
pressure (PETCO2) is inversely (r=-0.90, p<0.001) and minute ventilation (VE) is 
positively correlated with norepinephrine excretion rates (r=0.68, p<0.01). This 
is compatible with the concept that ventilatory parameters are partially 
responsible for activating sympathetic nerve activity. Interactions between 
ventilatory drive and sympathetic nerve activity during acute stimulation 
(hypoxia) of both peripheral and central chemoreceptors has been documented. 
Furthermore, reticulospinal neurons, acting as central oxygen sensors, are 
directly excited by hypoxia resulting in an initiation of sympathetic activity and 
circulatory adjustments. Increasing drive from chemoreceptors, as well as 
altered sensitivity, over time at altitude is potentially responsible for both the 
ventilatory and sympathetic adaptations during acclimatization. These 
mechanisms likely act to protect the brain from sustained hypoxia.  
Sympathetic neural release of norepinephrine is known to produce 
vasoconstriction via the α-adrenergic receptors resulting in an increase in 
vascular resistance. As a result, systemic vascular resistance is found to increase 
over time while at 4,300 m following a pattern very similar to that found for 
sympathetic nerve activity. This increase in vascular resistance translates into 
elevations in systemic arterial blood pressure over time at altitude, both of 
which appear to be directly related to the increase in sympathetic nerve activity. 
Additionally, our studies utilizing α-adrenergic blockade indicate that the 
changes in sympathetic nerve activity also play a role in the alterations in both 
substrate utilization as well as immune function during chronic altitude 
exposure. Our recent finding that the sympathetics via α-adrenergic 
mechanisms are responsible for the continued elevation in interluekin-6 while at 
altitude has implications for not only immune function but also the well-
documented finding of cachexia associated with high-altitude exposure. Thus, 
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alterations in sympathetic nerve activity have significant implications to both 
the physiologic and metabolic adjustments associated with acclimatization. 
 
Exercise:  After acclimatization, the adrenal medullary responsiveness 
during exercise has a pattern similar to that found at rest. Compared to arrival, 
arterial epinephrine levels are dramatically reduced returning toward sea level 
values, despite exercising at similar absolute as well as relative workloads.  
Similar findings have been reported by others confirming this acclimatization in 
adrenal medullary function during exercise. As at rest, it would appear that the 
improved arterial oxygen saturation associated with acclimatization is 
responsible for this adaptation during exercise.  
Compared to sea level and arrival at altitude, arterial norepinephrine levels 
and systemic vascular resistance are elevated throughout the duration of 
submaximal exercise, no matter whether the exercise was conducted at the same 
absolute or relative intensity. Similar increases are found for systemic vascular 
resistance during exercise. These findings are consistent with the chronic 
elevation in sympathetic nerve activity demonstrated under resting conditions.  
 
Immune response to acute hypoxia 
 
Regardless of the mechanism, it appears clear that acute exposure to 
altitude/hypoxia results in alterations of specific components of the immune 
system. Most prominent is the redistribution of T-lymphocytes with a notable 
reduction in CD4+ T-cell numbers as well as an impairment in T-cell activation 
and proliferation. Further, acute exposure to hypoxia has been reported to 
result in significant lymphopenia and neutrophilia that is quite similar to that 
observed in response to a single bout of exercise. B-lymphocyte number and 
function appear to be unaltered by altitude. In total, these studies indicate the 
short-term hypoxic exposure results in physiological responses known to 
mediate immune cell trafficking and function. 
Several studies have demonstrated that acute hypoxia results in increases in 
natural killer (NK) cell numbers and activity. This finding of enhanced NK cell 
number and activity appears to be transient as levels return to normal with 
more prolonged exposure to hypoxia. A potential mechanistic role involving the 
sympathoadrenal pathways was suggested. In support of this, epinephrine 
infusion can mimic the effect of hypoxia on NK cells while β-adrenergic 
blockade abolishes the increase in NK cell number. 
Recently, more attention has been directed toward examining the influence 
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of hypoxia on inflammatory cytokines. Upregulation of circulating IL-6, IL-1ra 
and CRP have been observed during short-term high altitude exposure and a 
role for these inflammatory cytokines in the development of high-altitude 
pulmonary edema (HAPE) has been suggested.   
It is now evident that the environmental stress of altitude/hypoxia 
exposure alone is sufficient to cause an elevation in circulating IL-6 even under 
resting conditions (independent of exercise stress). In cultured endothelial cells 
from mice acutely exposed to hypoxia, expression of IL-6 is dramatically 
increased. Similar results were reported in cultured rat neonatal cardiac 
myocytes after 4 hours of hypoxia. Klausen et al. examined the influence of 
acute hypoxia in humans and found serum IL-6 levels to be significantly 
increased while other proinflammatory cytokines remained unchanged. As 
indicated in, studies from the summit of Pikes Peak indicate that resting IL-6 
levels increase immediately upon arrival to altitude and remain elevated for 
several weeks while residing at 4300 m. Thus, both acute and chronic altitude 
exposure results in elevated resting IL-6 levels in humans. These results are 
consistent with observation that the elevation in IL-6 persists while subjects are 
becoming acclimatized to high-altitude exposure.  
It is known that the catecholamines can act as a potent stimulator for IL-6 
production and release into plasma, however, this effect has generally been 
thought to result from activation of the β-adrenergic pathways. Infusion of 
epinephrine has been reported to induce a dose-dependent increase in plasma 
IL-6 concentrations in the rat. Importantly, this epinephrine-induced increase in 
plasma IL-6 was blocked by the beta-adrenergic receptor antagonist 
propranolol. A separate study in rats found similar results with propranolol but 
also demonstrated that isoprenalin, a beta-2 adrenergic agonist, also elicited very 
high levels of plasma IL-6, indicating that the release of IL-6 can be mediated 
via the beta-2 adrenergic receptors. β-adrenergic stimulation of IL-6 production 
upon initial exposure to high altitude is consistent with the rapid increase in 
both epinephrine and IL-6 levels associated with acute hypoxia. 
However, the fact that resting IL-6 levels remain elevated over time at 
altitude while epinephrine levels return toward sea level values suggest that 
other mechanisms must be responsible to the sustained increase in IL-6. Recent 
evidence indicates that the SNS, via norepinephrine acting on the α-adrenergic 
receptors, is a primary factor responsible to the sustained elevation in IL-6 
levels over time at altitude. In the presence of α-adrenergic blockade (prazosin), 
the sustained increase in resting IL-6 levels is completely abolished. Thus, while 
resting IL-6 levels remained elevated throughout the 12 days duration at altitude 
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for the group receiving the placebo, IL-6 levels returned to sea level values by 
day 3 and remained there throughout the remainder of stay at altitude in 
subjects receiving a-adrenergic blockade. Thus, the presence of α-adrenergic 
blockade clearly influenced the IL-6 response to the chronic stress of hypoxia. 
The sustained elevation in IL-6 throughout the duration at altitude followed a 
similar pattern to that found for the increase in urinary norepinephrine 
excretion. Urinary norepinephrine excretion (a marker of overall sympathetic 
nerve activity) continued to increase steadily during days at altitude peaking at 
days 4-6. As norepinephrine has a strong affinity for the α-adrenergic receptors, 
this is a potential mechanism likely to contribute to the continued elevation in 
plasma IL-6 levels over time at altitude, particularly in the face of declining β-
adrenergic stimulation. This is supported by a significant correlation (p=0.004) 
between resting IL-6 and urinary norepinephrine excretion rates for subjects 
over the course of time while at altitude. Other studies have reported a similar 
relationship between peak plasma norepinephrine and IL-6 levels during high-
intensity exercise in humans.  
The physiological significance of the IL-6 response to hypoxia remains 
unknown, however, a number of possibilities have been suggested. It has been 
suggested that IL-6 can promote angiogenesis and may play a role via the 
induction of vascular endothelial growth factor (VEGF). Treatment of various 
cell lines with IL-6 for 6-48 h results in a significant induction of VEGF mRNA 
that is comparable to the documented induction of VEGF mRNA by hypoxia. 
Additionally, IL-6 can modulate production of erythropoietin (EPO) as the 
addition of IL-6 to hypoxic human hepatoma cells resulted in a dose-dependent 
stimulation of hypoxia-induced (EPO) production by as much as 81%. The 
associated increases in red blood cell number and oxygen carrying capacity are 
well-documented markers of adaptation to high altitude.  
 
Exercise at altitude: an added stressor  
 
There have been numerous studies documenting the effect of a single bout 
of exercise on immune function. Generally, depending upon the exercise 
intensity, duration and training status of the individual, exercise has been shown 
to be a physical stressor that can transiently affect immune function. However, 
there have been only a few studies that have examined the effect of exercise 
while at altitude on immune function. It is likely that, even when controlling for 
the relative exercise intensity (as VO2max and maximal performance capacity 
declines with ascending altitude), hypoxia represents an added stressor to that 
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imposed by exercise alone. Klokker et al. have shown that the combined effect 
of exercise and hypoxia result in a more dramatic effect on the NK cell 
response when compared to exercise in normoxic conditions. It was suggested 
that hypoxic exercise induces a more pronounced immunological stress 
response than exercise under sea level conditions.  
Recently, it has been demonstrated that when exercise is performed at the 
same relative metabolic stress (as indicated by similar blood lactate levels), 
exercise performed at altitude (1800 m) resulted in greater sympathetic 
activation compared to sea level. A greater exercise-induced increase in IL-6 
levels were also reported which correlated with the increase in circulating 
epinephrine and norepinephrine. These findings are consistent with the concept 
of an exacerbated immunological stress response when exercise and hypoxia are 
combined. Several studies have identified skeletal muscle as a potential source 
of circulating IL-6 during exercise and this is also likely to be the case with 
exercise at altitude. 
 Similar findings were observed during submaximal exercise under 
conditions of both acute and chronic altitude exposure (4300 m). IL-6 levels 
were elevated during exercise with acute altitude exposure, likely due to the 
exaggerated epinephrine response associated with initial exposure to hypoxia. 
As described above, this appears to be mediated primarily via β-adrenergic 
stimulation as α-adrenergic blockade had no effect in reducing the exercise-
induced increase in IL-6 during acute hypoxia. However, after these subjects 
had acclimatized for 12 days, α-adrenergic blockade significantly lowered IL-6 
levels similar to those found at sea level. The group receiving the placebo still 
demonstrated elevated IL-6 levels during exercise suggesting a strong α-
adrenergic component with more prolonged residence at high altitude. 
 Taken together, these studies suggest an additive effect of the physical 
stress imposed by exercise with that of hypoxic stress. This results in a more 
pronounced sympathoadrenal response which has implications for immune 
function. 
Training at altitude 
 
A number of studies have reported the benefits of altitude training for the 
endurance athlete with regard to improving sea level performance. Recently, it 
has been proposed that the ideal approach to maximize these benefits 
associated with acclimatization to altitude is the live high-train low model. This 
design calls for altitude exposure of at least 12-16 h/day for 3-4 weeks to elicit 
the desired adaptations (erythropoietin, red blood cell volume, etc) while 
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returning to a lower altitude for training. Training at altitude for sea level 
performance is not optimal as it impairs training quality (training velocity and 
absolute intensity) since VO2max and maximal performance capacity are 
reduced at altitude. 
Logistically, these studies are difficult to perform do to geographic 
limitations. Additionally, the use of hypobaric chambers is not ideal as it can 
lead to a disruption in sleep and eating patterns adversely affecting training, 
performance and immune function. Thus, to date, only one study has examined 
the effect of live high-train low on immune function. Tiollier et al.  examined 
the effect of live high-train low on mucosal immunity. Highly trained cross-
country skiers participated in an 18-day live high-train low training camp. The 
control group lived and trained at 1200 m while the live high-train low group 
trained at 1200 m but lived for 11 h/day in hypoxic rooms simulating an 
altitude of 2500, 3000 and 3500 m (six days at each altitude). Results indicated 
the salivary IgA concentrations decreased significantly over time in the live 
high-train low group but not in the control subjects. The findings suggested a 
cumulative adverse effect of exercise training and hypoxia on mucosal immunity 
over time at altitude. 
When athletes live and train at altitude, the influence of hypoxia on altering 
immune function is evident. Pyne et al. found that when members of the 
Australian Olympic swimming team were exposed to a 21-day training camp at 
2100 m, leukocyte numbers and ConA-induced blastogenesis was reduced 38 
and 32%, respectively when compared to sea level values.  
Finally, it is worth noting that some studies have provided support for 
training high while living at low altitude. When previously untrained individuals 
underwent 6 weeks of altitude training at 3850 m but lived at low altitude the 
remainder of the day, a significant upregulation of hypoxia inducible factor 1 
(HIF-1alpha mRNA) was observed.  No such training effect was found in 
subjects training under similar condition in normoxia. The combination of 
intense endurance training and hypoxia resulted in increases in VEGF mRNA 
and myoglobin mRNA suggesting hypoxic training improves various 
components associated with the transfer and utilization of oxygen. Impact of 
the train high-live low paradigm on immune function has not been investigated. 
Clearly, more studies need to be conducted to determine the extent to which 
these various training models involving altitude/hypoxia influence immune 
function and whether the actual susceptibility and incidence of illness is 
affected. 
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Conclusions 
 
It is clear that hypoxia and exercise are two independent stressors that can 
influence immune function. Initial exposure to hypoxia is a sufficient stressor 
that can elicit a neuroendocrine response that may alter immune function. 
While many components of the immune system are likely affected, alterations in 
T cell-mediated immunity are found to be the most consistent and robust. An 
acute bout of exercise is an added stressor at altitude that can exacerbate 
immune suppression, most likely through sympathoadrenal mediated pathways. 
An increased risk of infection is more likely during initial exposure to high 
altitude. As such, it would be advisable to allow athletes approximately one 
week to begin the acclimatization process before engaging in intense exercise 
training. With acclimatization, the hypoxic stress is lessened as CaO2 levels 
increase over time and adrenal medullary release of epinephrine returns towards 
sea level values. Consequently, T cell function approaches sea level values and 
the risk of infection wanes. Thus, the LHTL paradigm can be beneficial for 
endurance athletes and, when approached properly, should have minimal effects 
on immune function and illness. 
Future studies are warranted and should focus on elucidating the precise 
mechanisms responsible for alterations in immune function during hypoxic 
exposure. Additionally, there is a lack of information on the time course of 
these immunological changes as well as the extent to which the degree of 
hypoxia (or altitude elevation) influence these responses. Lastly, it is important 
to determine the clinical significance of these hypoxia-related changes in 
immune function and the extent to which the risk for infection is increased.  
 
Considerations 
 
Finally, a number of factors must be considered when discussing the 
interaction of altitude exposure and exercise on immune function. First, the 
altitude elevation or extent of the hypoxia is a primary factor that influences the 
degree of physiological stress, hormonal adjustments and immunological 
adaptations associated with exposure. Further, there is a minimum or threshold 
elevation that would be required to achieve the benefits associated with high 
altitude living while too high of an altitude could potentially have negative 
effects (sleep disruption, muscle loss) on not only immune function but 
performance as well. Second, the duration of stay and/or time spent at altitude 
will significantly impact both the extent and time course of key physiologic and 
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metabolic adaptations associated with the acclimatization process. Additionally, 
it is clear that, for a given altitude, there is inter-individual variability regarding 
the extent of these adaptations (e.g. - red cell volume, EPO, susceptibility to 
altitude sickness) as well as how the hypoxic stress is perceived by the body 
(differences in sympathoadrenal responses). Lastly, the potential benefits from 
the live high:train low paradigm are going to be event and training specific and 
will not necessarily result in improved performance. 
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